Technical analysis of gsk PHARMA

Embed Size (px)

Citation preview

  • 8/8/2019 Technical analysis of gsk PHARMA.

    1/63

    TECHNICAL ANALYSIS

    TERM PAPER

    ON

    TECHNICAL ANALYSIS OF GLAXOSMITHKLINE PHARMA

    Submitted To: Mr. Amarjit Saini Submitted By:

    LOVELY PROFESSIONAL UNIVERSITY Page 1

  • 8/8/2019 Technical analysis of gsk PHARMA.

    2/63

    TECHNICAL ANALYSIS

    Ajay kumar

    RS1902 B50

    Reg.no.-10906664

    LOVELY PROFESSIONAL UNIVERSITY Page 2

  • 8/8/2019 Technical analysis of gsk PHARMA.

    3/63

  • 8/8/2019 Technical analysis of gsk PHARMA.

    4/63

    TECHNICAL ANALYSIS

    INTRODUCTION

    GSK is one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organizations three priority

    diseases HIV/AIDS, tuberculosis and malaria, and are very proud to have developed some of the leading global medicines in these fields.

    Headquartered in the UK and with operations based in the US, GSK is one of the industry leaders, with an estimated seven per cent of the world's

    pharmaceutical market.

    But being a leader brings responsibility. This means that GSK care about the impact that its have on the people and places touched by our mission

    to improve health around the world.

    It also means that GSK must help developing countries where debilitating disease affects millions of people and access to life-changing medicines

    and vaccines is a problem. To meet this challenge, we are committed to providing discount medicines where they are needed the most.

    As a company with a firm foundation in science, GSK have a flair for research and a track record of turning that research into powerful,

    marketable drugs. Every hour GSK spend more than US$562,000 to find new medicines.

    GSK produce medicines that treat six major disease areas asthma, virus control, infections, mental health, diabetes and digestive conditions .

    In addition, GSK is a leader in the important area of vaccines and is developing new treatments for cancer.

    GSK also market other products, many of which are among the market leaders:

    Over-the-counter (OTC) medicines including Gaviscon and Panadol

    Dental products such as Aquafresh and Macleans

    Smoking control products Nicorette/Niquitin

    Nutritional healthcare drinks such as Lucozade, Ribena and Horlicks.

    LOVELY PROFESSIONAL UNIVERSITY Page 4

  • 8/8/2019 Technical analysis of gsk PHARMA.

    5/63

    TECHNICAL ANALYSIS

    LOVELY PROFESSIONAL UNIVERSITY Page 5

  • 8/8/2019 Technical analysis of gsk PHARMA.

    6/63

    TECHNICAL ANALYSIS

    G SKS WORLDWIDE MAP

    LOVELY PROFESSIONAL UNIVERSITY Page 6

  • 8/8/2019 Technical analysis of gsk PHARMA.

    7/63

    TECHNICAL ANALYSIS

    GSKWORLDWIDE

    EUROPE

    United Kingdom Cyprus Iceland Netherlands Spain

    Albania Czech Republic Ireland Norway Sweden

    LOVELY PROFESSIONAL UNIVERSITY Page 7

    http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/uk.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/cy.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/al.htmhttp://www.gsk.cz/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/cy.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/al.htmhttp://www.gsk.cz/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/uk.htm
  • 8/8/2019 Technical analysis of gsk PHARMA.

    8/63

    TECHNICAL ANALYSIS

    Austria Denmark Italy Poland Switzerland

    Armenia Estonia Kazakhstan Portugal Ukraine

    Belarus Finland Latvia Romania

    Belgium France Lithuania Russia

    Bosnia Herzegovina Germany Macedonia Serbia

    Bulgaria Greece Malta Slovakia

    Croatia Hungary Moldova Slovenia

    NORTH

    AMERICA

    United States Canada Mexico

    CENTRALAND SOUTH AMERICA

    Argentina Costa Rica Honduras Uruguay

    Brazil Ecuador Nicaragua Venezuela

    Chile El Salvador Panama

    Colombia Guatemala Peru

    CARIBBEAN

    Dominican Republic Jamaica Trinidad

    ASIAAND AUSTRALASIA

    Australia Hong Kong New Zealand Uzbekistan Azerbaijan India Pakistan

    Bangladesh Japan Sri Lanka China Korea Taiwan

    SOUTHEAST ASIA

    Cambodia Malaysia Philippines Thailand` Indonesia Myanmar SingaporeVietnam

    AFRICALOVELY PROFESSIONAL UNIVERSITY Page 8

    http://www.glaxosmithkline.at/http://www.glaxosmithkline.dk/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/am.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/ee.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/by.htmhttp://www.gsk.be/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/ba.htmhttp://www.gsk.bg/http://www.glaxosmithkline.hr/http://us.gsk.com/http://www.gsk.ca/http://www.gsk.com.mx/http://www.glaxosmithkline.com.ar/http://worldwide/cr.htmhttp://worldwide/hn.htmhttp://worldwide/uy.htmhttp://www.gsk.com.br/http://worldwide/ec.htmhttp://worldwide/ni.htmhttp://worldwide/ve.htmhttp://www.gsk.cl/http://worldwide/sv.htmhttp://worldwide/pa.htmhttp://www.gsk.com.co/http://worldwide/gt.htmhttp://worldwide/pe.htmhttp://worldwide/do.htmhttp://worldwide/jm.htmhttp://worldwide/tt.htmhttp://www.gsk.com.au/http://www.gsk.com.hk/http://gsk.co.nz/http://worldwide/uz.htmhttp://worldwide/az.htmhttp://worldwide/in.htmhttp://worldwide/in.htmhttp://www.gsk.com.pk/http://worldwide/bd.htmhttp://glaxosmithkline.co.jp/http://worldwide/lk.htmhttp://www.gsk-china.com/http://www.gskkorea.co.kr/http://www.gsk.tw/http://worldwide/kh.htmhttp://gsk.com.my/http://gsk.com.my/http://www.gsk.com.ph/http://worldwide/th.htmhttp://worldwide/id.htmhttp://worldwide/mm.htmhttp://worldwide/sg.htmhttp://worldwide/vn.htmhttp://www.glaxosmithkline.at/http://www.glaxosmithkline.dk/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/am.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/ee.htmhttp://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/by.htmhttp://www.gsk.be/http://tmp/sv8gm.tmp/mhtml:file:/E:/Rekha/projects/1st%20year%20project/im%20web%20page/GSK%20Worldwide%20-%20GlaxoSmithKline.mht!/worldwide/ba.htmhttp://www.gsk.bg/http://www.glaxosmithkline.hr/http://us.gsk.com/http://www.gsk.ca/http://www.gsk.com.mx/http://www.glaxosmithkline.com.ar/http://worldwide/cr.htmhttp://worldwide/hn.htmhttp://worldwide/uy.htmhttp://www.gsk.com.br/http://worldwide/ec.htmhttp://worldwide/ni.htmhttp://worldwide/ve.htmhttp://www.gsk.cl/http://worldwide/sv.htmhttp://worldwide/pa.htmhttp://www.gsk.com.co/http://worldwide/gt.htmhttp://worldwide/pe.htmhttp://worldwide/do.htmhttp://worldwide/jm.htmhttp://worldwide/tt.htmhttp://www.gsk.com.au/http://www.gsk.com.hk/http://gsk.co.nz/http://worldwide/uz.htmhttp://worldwide/az.htmhttp://worldwide/in.htmhttp://www.gsk.com.pk/http://worldwide/bd.htmhttp://glaxosmithkline.co.jp/http://worldwide/lk.htmhttp://www.gsk-china.com/http://www.gskkorea.co.kr/http://www.gsk.tw/http://worldwide/kh.htmhttp://gsk.com.my/http://www.gsk.com.ph/http://worldwide/th.htmhttp://worldwide/id.htmhttp://worldwide/mm.htmhttp://worldwide/sg.htmhttp://worldwide/vn.htm
  • 8/8/2019 Technical analysis of gsk PHARMA.

    9/63

    TECHNICAL ANALYSIS

    Algeria Morocco South Africa Kenya Nigeria

    INTRODUCTION OF THE COMPANY IN INDIA

    Established in the year 1924 in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and

    employs over 3500 people. Globally, we are a USD 42 billion, leading, research-based healthcare and pharmaceutical company. In India, we are

    one of the market leaders with a turnover of Rs. 1500 crore and a share of 6.9 per cent.

    The GSK India product portfolio includes:-

    Prescription medicines

    anti-infective

    dermatology

    gynecology

    diabetes

    LOVELY PROFESSIONAL UNIVERSITY Page 9

    http://worldwide/dz.htmhttp://worldwide/mo.htmhttp://worldwide/za.htmhttp://worldwide/ke.htmhttp://worldwide/ng.htmhttp://worldwide/dz.htmhttp://worldwide/mo.htmhttp://worldwide/za.htmhttp://worldwide/ke.htmhttp://worldwide/ng.htm
  • 8/8/2019 Technical analysis of gsk PHARMA.

    10/63

    TECHNICAL ANALYSIS

    cardiovascular disease

    respiratory diseases

    Vaccines

    Hepatitis A

    Hepatitis B

    Invasive disease caused by H

    Influenza

    Chickenpox

    Diphtheria Pertussis

    Tetanus and others.

    GSK India is aligning itself with the parent company in areas such as clinical trials, clinical data management, global pack management, sourcing

    raw material and support for business processes including analytics.

    GSKs best-in-class field force, backed by a nation-wide network of stockiest, ensures that the Companys products are readily available across

    the nation.

    GSK has two manufacturing units in India, located at Nasik and Thane as well as a clinical development centre in Bangalore. The state of art plant

    at Nasik makes formulations while bulk drugs are manufactured at Thane.

    Being a leader brings responsibility towards the communities in which we operate. At GSK we have a Corporate Social Responsibility program

    that works towards fulfilling basic healthcare, education and other developmental needs of 15 tribal villages near Nasik. We work with

    LOVELY PROFESSIONAL UNIVERSITY Page 10

  • 8/8/2019 Technical analysis of gsk PHARMA.

    11/63

    TECHNICAL ANALYSIS

    underprivileged children from the slums of Mumbai, taking care of their developmental and health

    needs. GSK also runs an HIV/AIDS helpline - considered to be a pioneering effort in India that

    supports those in distress and despair.

    GSK is committed to developing new and effective healthcare solutions. The values on which the group

    was founded have always inspired growth and will continue to do so in times to come.

    HISTORY 0F THE COMPANY

    GSK Company has a rich history that goes back to the early eighteenth century.

    1700-1799

    1715

    Plough Court pharmacy, the forerunner of Allen and Hanburys Ltd, is established in London by Silvanus Bevan.

    1800-1849

    1830

    John K Smith opens his first drugstore in Philadelphia. John's younger brother, George, joins him in 1841 to form John K Smith & Co.

    1850-1899

    LOVELY PROFESSIONAL UNIVERSITY Page 11

  • 8/8/2019 Technical analysis of gsk PHARMA.

    12/63

    TECHNICAL ANALYSIS

    1859

    Beecham opens the world's first factory to be built solely for making medicines at St Helens in England.

    1865

    Mahlon Kline joins Smith and Shoemaker - as John K Smith and Co had become - as a bookkeeper

    1873

    Joseph Nathan, who left the UK to seek new business opportunities 20 years before, establishes a general

    trading company at Wellington in New Zealand - Joseph Nathan and Co - the foundation for the Glaxo company to

    be formed later.

    1880

    Burroughs Well come & Company is established in London by American pharmacists Henry Well come and

    Silas Burroughs, four years after Joseph Nathan opened a London office.

    1884

    Tabloid is registered as a Burroughs Well come and Company trademark to describe its compressed tablets.

    1885

    Thomas Beecham's company acquires headquarters on the corner of Silver Street and Water Street, St Helens, England. Two years later, the

    company's new factory in St Helens becomes the first in the area to have electricity

    1900-1949

    1902

    The Well come Tropical Research Laboratories open

    1906LOVELY PROFESSIONAL UNIVERSITY Page 12

  • 8/8/2019 Technical analysis of gsk PHARMA.

    13/63

    TECHNICAL ANALYSIS

    Glaxo is registered by Joseph Nathan and Co as a trademark for dried milk. A Burroughs Well come subsidiary is created in New York.

    1908

    The Glaxo department of Joseph Nathan and Co opens in London and the first "baby book" is published.

    1913

    Production of Beecham's Pills laxative reaches one million a day.

    1919

    Alex C Maclean establishes MacLeans Ltd, manufacturing own-name products for chemists. Mahlon Kline begins the novel practice of sending

    pharmaceutical samples through the mail to doctors across the US.

    1945

    Beecham Group Ltd is established, replacing Beecham Pills Ltd and Beecham Estates Ltd - later known as Beecham Group plc - and incorporates

    Beecham Research Laboratories.

    1947

    Glaxo Laboratories Ltd absorbs the Joseph Nathan company and becomes the parent company. Glaxo is listed on the London Stock Exchange.

    New Beecham laboratories are established at Brockham Park in Surrey, England.

    1950-1999

    1958

    Glaxo acquires Allen and Hanburys Ltd.

    1959

    The Wellcome Foundation acquires Cooper, McDougall and Robertson Ltd, an animal health company founded in 1843.

    LOVELY PROFESSIONAL UNIVERSITY Page 13

  • 8/8/2019 Technical analysis of gsk PHARMA.

    14/63

    TECHNICAL ANALYSIS

    1970

    Burroughs Wellcome Inc moves its production facility from New York to Greenville, North Carolina.

    1978

    Through the acquisition of Meyer Laboratories Inc, Glaxo's business in the US is started, to become Glaxo Inc from 1980.

    1981

    The anti-ulcer treatment Zantac (ranitidine) is launched by Glaxo and is to become the world's top-selling medicine by 1986.

    1988

    SmithKline BioScience Laboratories acquires one of its largest competitors, International Clinical Laboratories, Inc, increasing the company's size

    by half and establishing SmithKline BioScience Laboratories as the industry leader.

    The Nobel Prize for medicine is awarded to George Hitchings and Gertrude Elion, of Burroughs Wellcome Inc, and to Sir James Black, who had

    worked at the Wellcome Foundation and Smith Kline and French Laboratories, "for their discoveries of important principles for drug treatment."

    1998

    SmithKline Beecham and the World Health Organization announce a collaboration to eliminate lymphatic filariasis (elephantiasis) by the year

    2020. The largest pharmaceutical company in Poland is created with the acquisition of Polfa Poznan by Glaxo Well come.

    2000-2001

    GlaxoSmithKline formed through the merger of Glaxo Well come and SmithKline Beecham.

    DEVELOPMENT OF THE COMPANY

    LOVELY PROFESSIONAL UNIVERSITY Page 14

  • 8/8/2019 Technical analysis of gsk PHARMA.

    15/63

    TECHNICAL ANALYSIS

    GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London

    Stock Exchange and the New York Stock Exchange. On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline

    Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies. Both Glaxo Well

    come and SmithKline Beecham were major global healthcare businesses.

    GSK plc and its subsidiary and associated undertakings constitute a major global healthcare group

    engaged in the creation, discovery, development, manufacture and marketing of

    pharmaceutical and consumer health-related products.

    GSK has its corporate head office in London. It also has operational headquarters in Philadelphia

    and Research Triangle Park, USA, and operations in some 114 countries, with products sold in over 140

    countries. The principal research and development (R&D) facilities are in the UK, the USA, Belgium,

    Italy, Japan and Spain. Products are currently manufactured in some 38 countries. The major markets for the Groups products are the USA,

    France, Japan, the UK, Italy, Germany and Spain.

    ORGANIZATION AWARDS

    Business in the community award

    Awards for diversity and our community work.

    Corporate equality, US Human Rights Campaign Foundation

    Best diversity company

    Diversity and equal treatment

    Business champion

    Energy management through resilience and mental wellbeing

    Most socially responsible company

    LOVELY PROFESSIONAL UNIVERSITY Page 15

  • 8/8/2019 Technical analysis of gsk PHARMA.

    16/63

    TECHNICAL ANALYSIS

    Most family friendly company

    Achieving significant milestones in leadership initiative

    Global Super Achiever award

    Excellence Through People standard

    Supporting the local community

    World-class health and safety excellence awards.

    Gold H.E.A.L.T.H award

    CEO cancer gold standard

    Best employers for healthy lifestyle gold award

    Unique workplace ergonomics

    Helping employees recognize health and performance links

    Awards for excellence 2007

    PRODUCT S OF THE COMPANY

    MEDICINES

    VACCINES

    CONSUMER HEALTHCAREBRANDS

    .

    LOVELY PROFESSIONAL UNIVERSITY Page 16

  • 8/8/2019 Technical analysis of gsk PHARMA.

    17/63

    TECHNICAL ANALYSIS

    COMPETITOR s CHART

    LOVELY PROFESSIONAL UNIVERSITY Page 17

  • 8/8/2019 Technical analysis of gsk PHARMA.

    18/63

    TECHNICAL ANALYSIS

    ORGANIZATION STRUCTURE

    (HIERARCHY)

    LOVELY PROFESSIONAL UNIVERSITY Page 18

  • 8/8/2019 Technical analysis of gsk PHARMA.

    19/63

    TECHNICAL ANALYSIS

    ORGANIZATION MANAGEMENT

    GSK Company is managed by the Board of Directors and the Corporate Executive Team.

    The Board is comprised of five executive and 11 non-executive directors who are responsible for our corporate governance and ultimately

    accountable for our activities, strategy and performance.

    The Chief Executive Officer (CEO) is responsible for the management of the business and is assisted by the Corporate Executive Team that

    manages our activities. Each member is responsible for a specific part of the business.

    BOARDS OF DIRECTORS

    The Board of Directors is responsible for GSK Company's corporate governance and ultimately accountable for our activities, strategy andperformance.

    NAME OF BOARD OF DIRECTORS

    Sir Christopher Gent - Non-Executive Chairman

    Andrew Witty - Chief Executive Officer

    Professor Sir Roy Anderson - Non-Executive Director

    Dr Stephanie Burns - Non-Executive Director

    Lawrence Culp - Non-Executive Director

    Sir Crispin Davis - Non-Executive Director

    Julian Heslop - Chief Financial Officer

    Sir Deryck Maughan - Non-Executive Director

    Dr Daniel Podolsky - Non-Executive Director

    LOVELY PROFESSIONAL UNIVERSITY Page 19

  • 8/8/2019 Technical analysis of gsk PHARMA.

    20/63

    TECHNICAL ANALYSIS

    Sir Ian Prosser - Senior Independent Non-Executive Director

    Dr Ronaldo Schmitz - Non-Executive Director

    Moncef Slaoui - Chairman, Research & Development

    Tom de Swaan - Non-Executive Director

    Chris Viehbacher - President, North American Pharmaceuticals

    Sir Robert Wilson - Non-Executive Director

    CORPORATE EXECUTIVE TEAM

    The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.

    Andrew Witty - Chief Executive Officer

    Simon Bicknell - Senior Vice President, Company Secretary & Compliance Officer

    John Clarke - President, Consumer Healthcare

    Marc Dunoyer - President, Asia Pacific/Japan

    Eddie Gray - President, Pharmaceuticals Europe

    Julian Heslop - Chief Financial Officer

    Abbas Hussain - President, Emerging Markets

    Duncan Learmouth - Senior Vice President, Corporate Communications and Community Partnerships

    Bill Louv - Chief Information Officer

    Dan Phelan - Chief of Staff

    LOVELY PROFESSIONAL UNIVERSITY Page 20

  • 8/8/2019 Technical analysis of gsk PHARMA.

    21/63

    TECHNICAL ANALYSIS

    David Pulman - President, Global Manufacturing and Supply

    David Redfern - Chief Strategy Officer

    Moncef Slaoui - Chairman, Research & Development

    Jean Stphenne - President and General Manager, Biological

    Claire Thomas - Senior Vice President, Human Resources

    Chris Viehbacher - President, North American Pharmaceuticals

    Bob Ingram - Vice Chairman, Pharmaceuticals

    ORGANIZATION

    STRUCTURE

    GSK S

    MANAGEMENT

    IN INDIA

    BOARDOF DIRECTORS

    D.S. Parekh - Chairman & Independent Director

    V. Thyagarajan - Vice-Chairman & Non - Executive Director

    LOVELY PROFESSIONAL UNIVERSITY Page 21

  • 8/8/2019 Technical analysis of gsk PHARMA.

    22/63

    TECHNICAL ANALYSIS

    Dr. H. B. Joshipura - Managing Director

    P. Bains - Non-Executive Director

    R. R. Bajaaj - Independent Director

    Dr. A. Banerjee - Executive Director - Technical

    M.B. Kapadia - Senior Executive Director

    N. Kaviratne - Independent Director

    P.V. Nayak - Independent Director

    V. Narayanan - Independent Director

    Dr. M. Reilly - Non-Executive Director

    R. Sequeira - Executive Director - Human Resources

    MANAGEMENT TEAM

    Dr. H. B. Joshipura - Chairman

    M.B. Kapadia - Senior Executive Director

    Dr. A. Banerjee - Executive Director - Technical

    R. Sequeira - Executive Director - Human Resources

    H. Singh - E.V. P - Pharmaceuticals

    M. K. Vasanth Kumar - E.V.P. - Information Technology & Supply Chain

    Dr. S. Joglekar - V.P. - Medical & Clinical Research

    S. Khanna - V.P. - Finance

    R. Limaye - V.P. - Marketing & Commercial Strategy

    LOVELY PROFESSIONAL UNIVERSITY Page 22

  • 8/8/2019 Technical analysis of gsk PHARMA.

    23/63

    TECHNICAL ANALYSIS

    S. Patel - V.P. - Legal & Corporate Affairs

    S. Rajan - General Manager - Corporate Communications

    WORLD TOPS PHARMACEUTICAL COMPANIES

    RANKING CORPORATION MARKET SHARE

    1 Pfizer 7.5%

    2 GSK Parma 6.9%

    3 Mercks Pharmaceutical 5.1%

    4 AstraZeneca 4.4%

    5 BMS 4.1%

    6 Novartis 3.9%

    7 Johnson 3.8%

    DIFFERENT TYPE OF ANALYSIS

    Technical Analysis

    Fundamental Analysis

    TECHNICAL ANALYSIS

    Technical Analysis operates on the theory that market prices at any given point in time reflect all known factors affecting supply and demand for

    a particular market. Consequently, technical analysis focuses, not on evaluating those factors directly, but on an analysis of market prices

    themselves. This approach theorize that a detailed analysis of, among other things, actual daily, weekly and monthly price fluctuations is the most

    effective means of attempting to capitalize on the future course of price movements. Technical strategies generally utilize a series of mathematical

    LOVELY PROFESSIONAL UNIVERSITY Page 23

  • 8/8/2019 Technical analysis of gsk PHARMA.

    24/63

    TECHNICAL ANALYSIS

    measurements and calculations designed to monitor market activity. Trading decisions are based on signals generated by charts, manual

    calculations, computers or their combinations.

    Fundamental Analysis is based on the study offactors external to the trading markets which affect the supply and demand of a particular

    market. It is in stark contrast to technical analysis since it focuses, not on price but on factors like weather, government policies, domestic and

    foreign political and economic events and changing trade prospects.

    Fundamental analysis theorizes that by monitoring relevant supply and demand factors for a particular market, a state of current or potential

    disequilibrium of market conditions may be identified before the state has been reflected in the price level of that market.

    Fundamental analysis assumes that markets are imperfect, that information is not instantaneously assimilated or disseminated and that

    econometric models can be constructed to generate equilibrium prices, which may indicate that current prices are inconsistent with underlying

    economic conditions, and will, accordingly, change in the future.

    laxoSmithKline Pharmaceutical Ltd.Historic Data since 01 Oct 2008 - 31 Sep 2010

    Moving Average Oscellators RSI

    DateOpenValue

    High LowCloseValue

    DailyAverage value

    10Days

    Movingaverag

    e

    20Days

    Movingaverag

    e

    30Days

    Movingaverag

    e

    Basisof 20th

    days

    Rate ofchange

    Gains(G)

    Loss(L)

    RunTest

    No.of

    Run

    LOVELY PROFESSIONAL UNIVERSITY Page 24

  • 8/8/2019 Technical analysis of gsk PHARMA.

    25/63

    TECHNICAL ANALYSIS

    1-Oct-08 1175 1194 1173.15

    1188.75

    1181.88

    3-Oct-08 1176 1183.85 1175

    1177.85

    1176.93-4.95 - 1

    6-Oct-08 1160 1170 1146.25 1155

    1157.5-19.43 -

    7-Oct-08 1145 1160 1060

    1150.75

    1147.88-9.625 -

    8-Oct-08 1063.8 1160 1040 1091.7

    1077.75-70.13 -

    10-Oct-08 1065 1082.9 1050

    1069.15

    1067.08-10.68 -

    13-Oct-08 1060 1095 1060 1085.05 1072.53 5.45 + 214-

    Oct-08 1100 1145 1082.51133.3

    51116.68

    44.1 +15-

    Oct-081110.6

    5 1144.25 1101 11351122.83

    6.15 +

    16-Oct-08 1060.1 1114 1060.1 1104.4

    1082.251120.33 -40.58 - 3

    17-Oct-08 1128.4 1128.4 1080.15 1089.2

    1108.81113.02 26.6 + 4

    20-Oct-08 1087 1113.9 1075 1104.9

    1095.951104.92 -12.85 - 5

    21-Oct-08 1083 1120 1082 1115.3

    1099.151099.09 3.2 + 6

    22-Oct-08 1122 1122 1095.25

    1097.55

    1109.781095.28 10.6 +

    23-Oct-08 1085 1085.5 1025.1 1040.6

    1062.81093.78 -46.98 - 7

    24-Oct-08 1029 1051 945 980.35

    1004.681087.54 -58.13 -

    LOVELY PROFESSIONAL UNIVERSITY Page 25

  • 8/8/2019 Technical analysis of gsk PHARMA.

    26/63

    TECHNICAL ANALYSIS

    27-Oct-08 950.9 1014 930 997.8

    974.351077.73 -30.33 -

    28-Oct-08 1010 1037.45 990.1 1002.7

    1006.351066.69 32 + 8

    29-Oct-08 991 1020.05 990

    1006.45

    998.7251054.28 -7.625 - 9

    31-Oct-08 1000 1080 989

    1070.35

    1035.181049.58 1084.95

    1181.88 -0.1241 36.4 + 10

    3-Nov-08

    1070.15 1104.8 1070.15 1098.8

    1084.481047.14 1080.08

    1176.93 -0.0786 49.3 +

    4-Nov-08 1071.4 1088 1070 1070.8

    1071.11044.66 1074.79

    1157.50 -0.0746 -13.38 - 11

    5-Nov-08 1098 1098 1025 1028.3 1063.15 1041.06 1070.07 1147.88 -0.0738 -7.95 -6-Nov-

    08 1020 1040 1000.51033.1

    51026.58

    1032.74 1064.011077.7

    5 -0.0475 -36.58 -7-Nov-

    08 1021.7 1080 1020 1063.71042.7

    1030.73 1062.261067.0

    8 -0.0228 16.1 + 1210-

    Nov-08 1074 1091 1060.25 1072.91073.45

    1037.61 1062.571072.5

    30.0008

    6 30.8 +11-

    Nov-08 1072.9 1090 1065.551078.6

    51075.78

    1047.75 1062.741116.6

    8 -0.0366 2.33 +12-

    Nov-08 1051.5 1070 1051 1060.5 1056 1052.71 1059.7

    1122.8

    3 -0.0595 -19.78 - 1314-

    Nov-08 1060 1075 1051.1 10701065

    1059.34 1056.811082.2

    5 -0.0159 9 + 1417-

    Nov-08 1095 1095 10501064.8

    51079.93

    1063.82 1056.7 1077.911108.8

    0 -0.026 14.9 +18-

    Nov-08 1050 1109 1049.9 1093.51071.75

    1062.54 1054.84 1074.241095.9

    5 -0.0221 -8.175 - 1519-

    Nov-08 1070.4 1095 1070.4 1081.11075.75

    1063.01 1053.83 1070.861099.1

    5 -0.0213 4 + 1620- 1075 1109 1061.15 1101 1088 1065.49 1053.28 1068.55 1109.7 -0.0196 12.3 +

    LOVELY PROFESSIONAL UNIVERSITY Page 26

  • 8/8/2019 Technical analysis of gsk PHARMA.

    27/63

    TECHNICAL ANALYSIS

    Nov-08 8

    21-

    Nov-08 1090 1131 1081.25 1125.71107.85

    1073.62 1053.18 1067.21

    1062.8

    0

    0.0423

    9 19.8 +24-

    Nov-081113.2

    5 1159.8 1113.251151.3

    51132.3

    1082.58 1056.65 1069.031004.6

    80.1270

    3 24.5 +25-

    Nov-08 1156.1 1190 1156.11173.3

    51164.73

    1091.71 1064.66 1072.29974.35

    0.19539 32.4 +

    26-Nov-08 1171 1171 1122.35 1150.3

    1160.651100.2 1073.97 1075.22

    1006.35

    0.15333 -4.075 - 17

    28-Nov-08 1100 1180 1100

    1166.35

    1133.181107.91 1080.31 1075.77

    998.730.1346

    2 -27.48 -1-Dec-

    08

    1154.6

    5 1175 1154.65

    1166.7

    5

    1160.7

    1117.48 1088.41 1077.04

    1035.1

    8

    0.1212

    6 27.5 + 182-Dec-08

    1140.85 1189.9 1100.05 1181.2

    1161.031125.59 1094.7 1079.66

    1084.48

    0.07059 0.33 +

    3-Dec-08 1181 1195 1170 1190.2

    1185.61136.98 1099.76 1082.22

    1071.10 0.1069 24.6 +

    4-Dec-08 1190 1190 1168.5 1179.9

    1184.951147.9 1105.45 1085.19

    1063.15

    0.11457 -0.65 - 19

    5-Dec-08 1180 1180 1150

    1150.05

    1165.031155.6 1110.55 1087.38

    1026.58

    0.13487 -19.93 -

    8-Dec-08 1169.9 1170 1140.15

    1149.75

    1159.831160.8 1117.21 1089.05

    1042.70

    0.11233 -5.2 -

    10-Dec-08 1167 1167 1125.1

    1132.45

    1149.731162.54 1122.56 1091.95

    1073.45

    0.07106 -10.1 -

    11-Dec-08 1121.1 1169.9 1121.1 1151.3

    1136.21159.69 1125.7 1096.33

    1075.78

    0.05617 -13.53 -

    12-Dec-08

    1151.05 1154.95 1127

    1135.55

    1143.31157.95 1129.07 1101.97

    1056.00

    0.08267 7.1 + 20

    15-Dec-08 1125 1145.3 1101 1116.2

    1120.61156.7 1132.3 1105.77

    1065.00

    0.05221 -22.7 - 21

    16-Dec-08 1110 1134 1110 1122.9

    1116.451152.27 1134.88 1109.7

    1079.93

    0.03382 -4.15 -

    LOVELY PROFESSIONAL UNIVERSITY Page 27

  • 8/8/2019 Technical analysis of gsk PHARMA.

    28/63

    TECHNICAL ANALYSIS

    17-Dec-08 1134.8 1139 1103

    1130.35

    1132.581149.43 1137.51 1112.94

    1071.75

    0.05675 16.1 + 22

    18-Dec-08 1148.4 1148.4 1115.1 1136.1

    1142.251145.09 1141.03 1114.87

    1075.75

    0.06182 9.68 +

    19-Dec-08 1124.7 1145 1120 1125.5

    1125.11139.11 1143.5 1116.67

    1088.00 0.0341 -17.15 - 23

    22-Dec-08 1129.8 1138 1112.3 1116.1

    1122.951134.9 1145.25 1118.66

    1107.85

    0.01363 -2.15 -

    23-Dec-08

    1109.05 1124.9 1109.05 1113.6

    1111.331130.05 1145.42 1121.49

    1132.30 -0.0185 -11.63 -

    24-Dec-08 1110 1122.75 1107.1 1117.8

    1113.91126.47 1144.5 1123.86

    1164.73 -0.0436 2.58 + 24

    26-Dec-08 1127.8 1129.7 1112.5 1126.05 1126.93 1125.54 1142.61 1125.64 1160.65 -0.0291 13 +29-

    Dec-08 1112.5 1145 1110.2 1140.61126.55

    1123.86 1140.91 1127.341133.1

    8 -0.0058 -0.375 - 2530-

    Dec-08 1135 1155 1130 11501142.5

    1126.05 1141.37 1130.221160.7

    0 -0.0157 16 + 2631-

    Dec-08 1170 1170 1144 11471158.5

    1130.26 1141.26 1133.341161.0

    3 -0.0022 16 +1-Jan-

    09 1126.4 1159.95 1126.4 1151.21138.8

    1130.88 1140.15 1135.31185.6

    0 -0.0395 -19.7 - 272-Jan-

    09 1145 1155 1145

    1147.3

    5 1146.18 1131.27 1138.18 1137.78

    1184.9

    5 -0.0327 7.37 + 285-Jan-

    09 1146 1149 1137.05 11461146

    1133.36 1136.23 1140.121165.0

    3 -0.0163 -0.175 - 296-Jan-

    091140.0

    5 1153 11401145.2

    51142.65

    1135.33 1135.12 1141.941159.8

    3 -0.0148 -3.35 -7-Jan-

    091149.9

    5 1149.95 1113.15 1122.31136.13

    1137.81 1133.93 1142.891149.7

    3 -0.0118 -6.525 -9-Jan-

    09 1128.8 1140 1105 11221125.4

    1138.96 1132.71 1142.661136.2

    0 -0.0095 -10.72 -12-Jan- 1111 1157.85 1105.15 1147.7 1129.38 1139.21 1132.37 1141.48 1143.3 -0.0122 3.97 + 30

    LOVELY PROFESSIONAL UNIVERSITY Page 28

  • 8/8/2019 Technical analysis of gsk PHARMA.

    29/63

    TECHNICAL ANALYSIS

    09 5 0

    13-Jan-

    09

    1137.1

    5 1161 1135 1155.31146.23

    1141.18 1132.52 1141

    1120.6

    0

    0.0228

    7 16.8 +14-Jan-

    09 1160 1160 1140 1147.91153.95

    1142.32 1134.19 1141.691116.4

    50.0335

    9 7.73 +15-Jan-

    09 1150 1162 1149.951156.3

    51153.18

    1141.79 1136.02 1141.441132.5

    80.0181

    9 -0.775 - 3116-Jan-

    091144.7

    5 1175 1144.751167.0

    51155.9

    1143.5 1137.19 1141.271142.2

    50.0119

    5 2.73 + 3219-Jan-

    09 1161.6 1164.1 11551163.3

    51162.48

    1145.13 1138.2 1140.51125.1

    00.0332

    2 6.57 +20-Jan-

    09 1150 1164 1146.25

    1160.0

    5

    1155.03

    1146.03 1139.7 1139.5

    1122.9

    5

    0.0285

    6 -7.45 - 3321-Jan-09 1164.8 1176 1159.95

    1169.95

    1167.381148.5 1141.92 1139.58

    1111.33

    0.05044 12.3 + 34

    22-Jan-09 1151 1182.1 1118.4 1174.5

    1162.751151.17 1144.49 1139.68

    1113.90

    0.04385 -4.625 - 35

    23-Jan-09 1162.5 1178 1160

    1173.65

    1168.081155.43 1147.2 1140.29

    1126.93

    0.03652 5.33 + 36

    27-Jan-09 1160 1177 1160

    1169.85

    1164.931158.99 1149.1 1141.24

    1126.55

    0.03406 -3.15 - 37

    28-Jan-09 1180 1180 1151 1160.3

    1170.151161.38 1151.28 1142.14

    1142.50 0.0242 5.23 + 38

    29-Jan-09 1173 1173 1140

    1148.55

    1160.781162.06 1152.19 1143.48

    1158.50

    0.00196 -9.375 - 39

    30-Jan-09 1136 1171.9 1135 1165.8

    1150.91161.84 1151.81 1144.63

    1138.80

    0.01063 -9.875 -

    2-Feb-09 1151.2 1169 1151

    1157.45

    1154.331161.68 1152.59 1145.35

    1146.18

    0.00711 3.42 + 40

    3-Feb-09 1153.5 1159 1150 1150.2

    1151.851160.62 1152.87 1145.67

    1146.00 0.0051 -2.475 - 41

    4-Feb-09

    1151.25 1152.05 1135 1138.2

    1144.731159.59 1152.81 1146.33

    1142.65

    0.00182 -7.125 -

    LOVELY PROFESSIONAL UNIVERSITY Page 29

  • 8/8/2019 Technical analysis of gsk PHARMA.

    30/63

    TECHNICAL ANALYSIS

    5-Feb-09 1140 1145 1135 1135.5

    1137.751156.62 1152.56 1146.82

    1136.13

    0.00143 -6.975 -

    6-Feb-09 1146.7 1158 1133.1

    1154.45

    1150.581155.41 1153.29 1148.13

    1125.40

    0.02237 12.8 + 42

    9-Feb-09

    1154.95 1160 1140.5 1148.1

    1151.531153.75 1154.59 1149.38

    1129.38

    0.01961 0.95 +

    10-Feb-09 1159 1159 1135

    1140.65

    1149.831152.24 1155.61 1150.15

    1146.23

    0.00314 -1.7 - 43

    11-Feb-09

    1144.95 1162 1144.95 1156.4

    1150.681150.29 1155.84 1150.95

    1153.95 -0.0028 0.85 + 44

    12-Feb-09 1166.8 1166.8 1154

    1158.85

    1162.831150.5 1156.28 1151.63

    1153.18

    0.00837 12.1 +

    13-Feb-09 1162 1168 1154.25 1159.35 1160.68 1151.48 1156.66 1151.7 1155.90 0.00413 -2.15 - 4516-

    Feb-091164.8

    5 1180 1161.6 1167.61166.23

    1152.67 1157.17 1152.611162.4

    80.0032

    3 5.55 + 4617-

    Feb-09 1167.3 1198.5 1156.1 1190.61178.95

    1155.38 1158 1153.711155.0

    30.0207

    1 12.7 +18-

    Feb-09 1199 1233.7 1189.95 1196.71197.85

    1160.69 1160.14 1155.431167.3

    80.0261

    1 18.9 +19-

    Feb-09 1213.8 1214 1182.1 1191.31202.55

    1167.17 1161.9 1157.431162.7

    50.0342

    3 4.7 +20-

    Feb-09

    1185.5

    5 1190 1171.2 1176.6 1181.08 1170.22 1162.81 1158.93

    1168.0

    8

    0.0111

    3 -21.48 - 4724-

    Feb-09 1169 1200 11601181.2

    51175.13

    1172.58 1163.16 1160.591164.9

    30.0087

    6 -5.95 -25-

    Feb-091199.4

    5 1199.45 1180.11182.0

    51190.75

    1176.67 1164.46 1162.631170.1

    5 0.0176 15.6 + 4826-

    Feb-09 1180 1181 11721177.5

    51178.78

    1179.48 1164.89 1163.721160.7

    80.0155

    1 -11.97 - 4927-

    Feb-09 1175 1203.75 11751199.9

    51187.48

    1181.95 1166.22 1164.841150.9

    00.0317

    8 8.7 + 50

    LOVELY PROFESSIONAL UNIVERSITY Page 30

  • 8/8/2019 Technical analysis of gsk PHARMA.

    31/63

    TECHNICAL ANALYSIS

    3-Mar-09

    1191.05 1214 1162.2 1181.8

    1186.431184.52 1168 1165.94

    1154.33

    0.02781 -1.05 - 51

    4-Mar-09 1197 1197 1168 1180.1

    1188.551186.75 1169.71 1167.03

    1151.85

    0.03186 2.13 + 52

    5-Mar-09 1190 1190 1170 1186.7

    1188.351187.69 1171.53 1167.89

    1144.73

    0.03811 -0.2 - 53

    6-Mar-09 1184.4 1201.8 1173.7 1199.1

    1191.751187.08 1173.89 1169.12

    1137.75

    0.04746 3.4 + 54

    9-Mar-09 1182 1200 1182 1189.8

    1185.91185.42 1176.29 1169.74

    1150.58 0.0307 -5.85 - 55

    12-Mar-09 1185 1185.15 1173.15 1176.7

    1180.851185.4 1177.81 1170.34

    1151.53

    0.02547 -5.05 -

    13-Mar-09 1188 1188.8 1168 1169.9 1178.95 1185.78 1179.18 1170.7

    1149.83

    0.02533 -1.9 -

    16-Mar-09 1178.8 1178.8 1150 1156.3

    1167.551183.46 1180.06 1170.79

    1150.68

    0.01467 -11.4 -

    17-Mar-09 1159.9 1163.8 1150.1

    1155.85

    1157.881181.37 1180.42 1170.38

    1162.83 -0.0043 -9.675 -

    18-Mar-09 1142 1154.7 1080.15

    1097.85

    1119.931174.61 1178.28 1169.02

    1160.68 -0.0351 -37.95 -

    19-Mar-09 1110 1120 1080.1

    1101.85

    1105.931166.56 1175.54 1167.52

    1166.23 -0.0517 -14 -

    20-

    Mar-09

    1082.0

    5 1099.9 1074 1075.2 1078.63 1155.57 1171.16 1165

    1178.9

    5 -0.0851 -27.3 -23-

    Mar-09 1075 1086 1037.051041.8

    51058.43

    1142.58 1165.14 1161.881197.8

    5 -0.1164 -20.2 -24-

    Mar-091140.0

    5 1140.05 10351045.3

    51092.7

    1132.67 1159.88 1160.151202.5

    5 -0.0913 34.3 + 5625-

    Mar-09 1047.8 1067.4 1036.51052.3

    51050.08

    1119.09 1152.25 1157.231181.0

    8 -0.1109 -42.63 - 5726-

    Mar-09 1063.9 1073.9 1053.05 1063.71063.8

    1107.39 1146.39 1154.331175.1

    3 -0.0947 13.7 + 58

    LOVELY PROFESSIONAL UNIVERSITY Page 31

  • 8/8/2019 Technical analysis of gsk PHARMA.

    32/63

    TECHNICAL ANALYSIS

    27-Mar-09 1060 1071.7 1060

    1068.15

    1064.081095.9 1140.84 1151.42

    1190.75 -0.1064 0.27 +

    30-Mar-09 1066.95 1090 1064 1076.45 1071.7 1086.31 1134.89 1148.81 1178.78 -0.0908 7.63 +31-

    Mar-09 1080 1113 10731088.0

    51084.03

    1078.93 1130.15 1146.591187.4

    8 -0.0871 12.3 +1-Apr-

    09 1090 1095 1085 1088.21089.1

    1075.85 1125.23 1144.131186.4

    3 -0.082 5.07 +2-Apr-

    09 1081 1097 10801087.7

    51084.38

    1073.69 1120.13 1141.591188.5

    5 -0.0876 -4.725 - 596-Apr-

    091087.1

    5 1089 10801085.7

    51086.45

    1074.47 1115.02 1138.931188.3

    5 -0.0857 2.08 + 608-Apr-

    09 1080 1089.5 1070 1084.2 1082.1 1076.84 1109.71 1135.71191.7

    5 -0.092 -4.35 - 619-Apr-

    09 1075.5 1104.9 1065.651093.3

    51084.43

    1076.01 1104.34 1131.921185.9

    0 -0.0856 2.33 + 6213-

    Apr-09 1075 1119.5 10751112.7

    51093.88

    1080.39 1099.74 1128.31180.8

    5 -0.0737 9.45 +15-

    Apr-09 1080 1111 1080 11051092.5

    1083.26 1095.32 1125.351178.9

    5 -0.0733 -1.375 - 6316-

    Apr-091114.9

    5 1114.95 10951099.0

    51107

    1087.56 1091.73 1123.081167.5

    5 -0.0519 14.5 + 6417-

    Apr-09 1108.8 1125 1097.45 1115.8 1112.3 1091.62 1088.96 1120.46

    1157.8

    8 -0.0394 5.3 +20-

    Apr-09 1114.9 1138.7 1113.8 1133.21124.05

    1095.62 1087.27 1118.641119.9

    30.0036

    8 11.8 +21-

    Apr-09 1127.6 1174 11251164.3

    51145.98

    1101.31 1088.58 1117.251105.9

    30.0362

    1 21.9 +22-

    Apr-09 1160 1180 1160 1172.81166.4

    1109.51 1091.6 1116.591078.6

    30.0813

    8 20.4 +23-

    Apr-09 1172 1180 1165 1175.41173.7

    1118.23 1096.35 1116.091058.4

    30.1089

    1 7.3 +

    LOVELY PROFESSIONAL UNIVERSITY Page 32

  • 8/8/2019 Technical analysis of gsk PHARMA.

    33/63

    TECHNICAL ANALYSIS

    24-Apr-09 1167.5 1179.9 1167.15 1168.1

    1167.81126.8 1101.82 1115.41

    1092.70

    0.06873 -5.9 - 65

    27-Apr-09 1167.3 1185 1167 1167.35 1167.33 1135.09 1105.55 1114.59 1050.08 0.11166 -0.475 -28-

    Apr-091177.9

    5 1215 1168 1178.51178.23

    1143.53 1111.96 1114.341063.8

    00.1075

    6 10.9 + 6629-

    Apr-09 1170.1 1187.5 11671173.9

    51172.03

    1151.48 1117.37 1114.041064.0

    80.1014

    5 -6.2 - 674-May-

    09 1157 1184.9 11571169.7

    51163.38

    1157.12 1122.34 1113.521071.7

    00.0855

    4 -8.65 -5-May-

    09 1167.5 1173.05 1163.35 1165.91166.7

    1162.56 1127.09 1113.51084.0

    30.0762

    7 3.33 + 686-May-

    09 1172 1172 1160 1163.8 1167.9 1166.94 1131.28 1113.831089.1

    00.0723

    5 1.2 +7-May-

    09 1164.5 1172 1164.5 1169.81167.15

    1169.06 1135.18 1115.41084.3

    80.0763

    3 -0.75 - 698-May-

    09 1199 1251 1167.15 1171.91185.45

    1170.97 1140.24 1118.051086.4

    50.0911

    2 18.3 + 7011-

    May-09 1168 1173 1165 1166.1

    1167.051170.3 1144.27 1121

    1082.10

    0.0785 -18.4 - 7112-

    May-

    09 1168 1169 1161.6

    1165.2

    5

    1166.63

    1170.18 1148.49 1124.61

    1084.4

    3 0.0758 -0.425 -13-

    May-09 1081.2 1170.6 1081.2 1164.8

    11231165.75 1150.42 1125.62

    1093.88

    0.02663 -43.63 -

    14-May-

    09 1160 1177.2 11481169.4

    51164.73

    1164.4 1153.96 1129.44

    1092.50

    0.06611 41.7 + 72

    15-May-

    09 1189 1191 1165.65 1170.61179.8

    1165.18 1158.33 1133.31

    1107.00

    0.06576 15.1 +

    LOVELY PROFESSIONAL UNIVERSITY Page 33

  • 8/8/2019 Technical analysis of gsk PHARMA.

    34/63

    TECHNICAL ANALYSIS

    18-May-

    09 1230 1250 1222 1250

    1240

    1172.84 1164.98 1139.17

    1112.30

    0.1148

    1 60.2 +19-May-

    09 1210 1210.1 1092.3 1118.81164.4

    1172.61 1167.58 1142.26

    1124.05

    0.0359 -75.6 - 7320-

    May-09 1124.8 1150 1121

    1141.15

    1132.981169.12 1168.03 1143.89

    1145.98

    -0.0113 -31.43 -21-

    May-09 1138 1149.5 1070

    1092.35

    1115.181163.92 1166.49 1144.76

    1166.40

    -0.0439 -17.8 -22-

    May-09 1108.8 1108.8 1086 1094.4

    1101.61155.54 1163.25 1145.34

    1173.70

    -0.0614 -13.58 -25-

    May-09 1109 1116 1098 1107.9

    1108.451149.68 1159.99 1146.07

    1167.80

    -0.0508 6.85 + 7426-

    May-09 1129 1152 1125 1134.6

    1131.81146.19 1158.19 1147.73

    1167.33

    -0.0304 23.3 +27-

    May-

    09 1140 1155 1135 1145.2

    1142.6

    1148.15 1156.95 1149.67

    1178.2

    3 -0.0302 10.8 +28-

    May-09 1160 1174 1141.15 1157

    1158.51147.53 1155.97 1151.82

    1172.03

    -0.0115 15.9 +29-

    May-09 1164.7 1178 1157.05 1163.3

    11641145.95 1155.56 1154.2

    1163.38

    0.00054 5.5 +

    1-Jun-09 1165 1193 1157 1180.2

    1172.61139.21 1156.03 1156.39

    1166.70

    0.00506 8.6 +

    LOVELY PROFESSIONAL UNIVERSITY Page 34

  • 8/8/2019 Technical analysis of gsk PHARMA.

    35/63

    TECHNICAL ANALYSIS

    2-Jun-09 1175.1 1208 1175.1 1202.7

    1188.91141.66 1157.14 1158.94

    1167.90

    0.01798 16.3 +

    3-Jun-09 1208 1212 1200 1201.4 1204.7 1148.83 1158.98 1161.63 1167.15 0.03217 15.8 +4-Jun-

    091209.9

    5 1220 12001207.9

    51208.95

    1158.21 1161.07 1163.731185.4

    50.0198

    2 4.25 +5-Jun-

    09 1215 1250 1206.61219.2

    51217.13

    1169.76 1162.65 1165.421167.0

    50.0429

    1 8.17 +8-Jun-

    09 1212.5 1230 1210 12151213.75

    1180.29 1164.98 1166.761166.6

    30.0403

    9 -3.375 - 759-Jun-

    091210.1

    5 1274 12101248.8

    51229.5

    1190.06 1168.13 1168.811123.0

    00.0948

    4 15.8 + 7610-Jun-

    09 1254 1276 1250 1267.7 1260.85 1201.89 1175.02 1171.931164.7

    30.0825

    3 31.3 +11-Jun-

    09 1262.1 1275 1254.25 1270.71266.4

    1212.68 1180.1 1174.871179.8

    0 0.0734 5.55 +12-Jun-

    09 1294.7 1294.7 12361247.7

    51271.23

    1223.4 1184.68 1178.181240.0

    00.0251

    8 4.82 +15-Jun-

    09 1299 1299 1230.21252.1

    51275.58

    1233.7 1186.45 1181.921164.4

    00.0954

    8 4.35 +16-Jun-

    09 1277 1280 1231 1250.31263.65

    1241.17 1191.42 1185.151132.9

    80.1153

    4 -11.93 - 7717-Jun-

    09 1240 1280 1235 1259.8 1249.9 1245.69 1197.26 1187.88

    1115.1

    8

    0.1208

    1 -13.75 -18-Jun-

    091250.0

    5 1259.95 1235 12421246.03

    1249.4 1203.81 1190.511101.6

    0 0.1311 -3.875 -19-Jun-

    09 1235.8 1245 1190 1208.81222.3

    1249.92 1209.84 1191.741108.4

    50.1027

    1 -23.73 -22-Jun-

    09 1225 1230 11951210.1

    51217.58

    1250.3 1215.3 1193.421131.8

    00.0757

    9 -4.725 -23-Jun-

    091201.2

    5 1225 12001206.6

    51203.95

    1247.75 1218.9 1194.671142.6

    00.0536

    9 -13.63 -

    LOVELY PROFESSIONAL UNIVERSITY Page 35

  • 8/8/2019 Technical analysis of gsk PHARMA.

    36/63

    TECHNICAL ANALYSIS

    24-Jun-09 1203 1235 1197.45

    1224.65

    1213.831243.04 1222.47 1197.69

    1158.50

    0.04776 9.88 + 78

    25-Jun-09 1220.15 1239.7 1213 1221.25 1220.7 1238.47 1225.58 1199.56 1164.00 0.04871 6.88 +26-Jun-

    09 1238.8 1245 1212.1 1232.11235.45

    1234.9 1229.15 1201.421172.6

    0 0.0536 14.7 +29-Jun-

    09 1150 1237.3 11501213.9

    51181.98

    1225.54 1229.62 1199.481188.9

    0 -0.0058 -53.47 - 7930-Jun-

    09 1230 1230 1170 1194.21212.1

    1220.38 1230.78 1201.071204.7

    00.0061

    4 30.1 + 801-Jul-

    091199.3

    5 1225 1195.051217.9

    51208.65

    1216.26 1230.97 1203.591208.9

    5 -0.0002 -3.45 - 812-Jul-

    09 1205 1270 1205 1252.8 1228.9 1214.54 1231.97 1207.381217.1

    30.0096

    7 20.3 + 823-Jul-

    09 1260.1 1281 1257.2 12721266.05

    1218.92 1234.42 1212.871213.7

    50.0430

    9 37.1 +6-Jul-

    091275.0

    5 1289 12551265.8

    51270.45

    1224.21 1237.25 1218.271229.5

    00.0333

    1 4.4 +7-Jul-

    09 1271 1300 12701290.4

    51280.73

    1231.88 1239.81 1223.231260.8

    50.0157

    6 10.3 +8-Jul-

    09 1270 1272.9 1253 1260.91265.45

    1237.05 1240.04 1227.331266.4

    0 -0.0008 -15.27 - 8310-Jul-

    09 1260.1 1264.95 1228.3 1246.3 1253.2 1240.3 1239.38 1230.48

    1271.2

    3 -0.0142 -12.25 -13-Jul-

    091228.5

    5 1262.8 1228.551250.6

    51239.6

    1240.71 1237.8 12331275.5

    8 -0.0282 -13.6 -14-Jul-

    091258.9

    5 1280 1251.11277.4

    51268.2

    1249.33 1237.43 1236.191263.6

    5 0.0036 28.6 + 8415-Jul-

    09 1279.9 1318.95 1272.3 1291.91285.9

    1256.71 1238.55 1239.421249.9

    0 0.0288 17.7 +16-Jul-

    09 1295 1309.95 1281 1303.71299.35

    1265.78 1241.02 1242.581246.0

    3 0.0428 13.4 +

    LOVELY PROFESSIONAL UNIVERSITY Page 36

  • 8/8/2019 Technical analysis of gsk PHARMA.

    37/63

    TECHNICAL ANALYSIS

    17-Jul-09 1303.7 1309.9 1270 1288.4

    1296.051272.5 1243.52 1245.48

    1222.30

    0.06034 -3.3 - 85

    20-Jul-09 1288.4 1300 1284.05 1290.1 1289.25 1274.82 1246.87 1247.88 1217.58 0.05887 -6.8 -21-Jul-

    09 1285 1296.45 12851292.5

    51288.78

    1276.65 1250.43 1250.391203.9

    50.0704

    6 -0.475 -22-Jul-

    09 1290 1310 1290 1306.21298.1

    1278.39 1255.14 1252.671213.8

    30.0694

    3 9.32 + 8623-Jul-

    09 1310 1340 13101335.7

    51322.88

    1284.13 1260.59 1254.741220.7

    0 0.0837 24.8 +24-Jul-

    091335.7

    5 1350 1312.51328.0

    51331.9

    1292 1266.15 1256.921235.4

    50.0780

    7 9.03 +27-Jul-

    09 1349 1350 12681347.3

    5 1348.18 1302.86 1271.78 1259.491181.9

    80.1406

    1 16.3 +28-Jul-

    09 1350 1355 1330.051351.1

    51350.58

    1311.1 1280.21 1261.991212.1

    00.1142

    4 2.4 +29-Jul-

    09 1345 1361 1325 13541349.5

    1317.46 1287.08 1264.851208.6

    50.1165

    3 -1.075 - 8730-Jul-

    09 1350 1359.9 13501352.1

    51351.08

    1322.63 1294.21 1268.221228.9

    00.0994

    2 1.58 + 8831-Jul-

    09 1285.5 1370 1285.51361.5

    51323.53

    1325.38 1298.94 1270.811266.0

    5 0.0454 -27.55 - 893-Aug-

    09 1340 1400.45 1330 1385.2 1362.6 1332.71 1303.76 1275.48

    1270.4

    5

    0.0725

    3 39.1 + 904-Aug-

    09 1394.9 1415 1380.41387.1

    51391.03

    1342.94 1309.79 1281.261280.7

    30.0861

    2 28.4 +5-Aug-

    09 1376.1 1388 1350 13731374.55

    1350.58 1314.48 1286.951265.4

    50.0862

    1 -16.48 - 916-Aug-

    09 1356 1384.8 13521361.6

    51358.83

    1354.18 1319.15 1291.781253.2

    00.0842

    8 -15.72 -7-Aug-

    09 1359 1360.05 13471351.5

    51355.28

    1356.51 1324.26 1296.271239.6

    00.0933

    2 -3.55 -

    LOVELY PROFESSIONAL UNIVERSITY Page 37

  • 8/8/2019 Technical analysis of gsk PHARMA.

    38/63

    TECHNICAL ANALYSIS

    10-Aug-09 1388 1388 1345.4 1348.5

    1368.251358.52 1330.69 1300.7

    1268.20

    0.07889 13 + 92

    11-Aug-09 1424 1440 1309.05 1357.9 1390.95 1362.56 1336.83 1307.66 1285.90 0.08169 22.7 +12-

    Aug-09 1366.5 1411 1364.15 1394.81380.65

    1365.67 1341.56 1313.281299.3

    50.0625

    7 -10.3 - 9313-

    Aug-09 1424 1440.9 1403.051431.2

    51427.63

    1373.33 1347.98 1320.581296.0

    50.1015

    2 47 + 9414-

    Aug-09 1435 1455 14221433.6

    51434.33

    1384.41 1354.89 1327.431289.2

    50.1125

    3 6.7 +17-

    Aug-09 1420 1439.75 14151422.5

    51421.28

    1390.28 1361.49 1332.61288.7

    80.1028

    1 -13.05 - 9518-

    Aug-09 1444 1444 1415.6 1431 1437.5 1394.92 1368.93 1338.171298.1

    00.1073

    9 16.2 + 9619-

    Aug-09 1436 1460 14321453.2

    51444.63

    1401.93 1376.26 1343.631322.8

    80.0920

    3 7.13 +20-

    Aug-09 1460.5 1465 14401448.0

    51454.28

    1411.48 1382.83 1349.931331.9

    00.0918

    8 9.65 +21-

    Aug-09 1435 1443 1425.051430.5

    51432.78

    1419.23 1387.87 1355.911348.1

    80.0627

    5 -21.5 - 9724-

    Aug-09 1430 1430 1413 14221426

    1425 1391.76 1362.131350.5

    80.0558

    5 -6.775 -25-

    Aug-09 1410 1420 1392 1409.2 1409.6 1426.87 1394.71 1366.84

    1349.5

    0

    0.0445

    4 -16.4 -26-

    Aug-09 1401 1420 1401 1412.31406.65

    1429.47 1397.57 1370.861351.0

    80.0411

    3 -2.95 -27-

    Aug-091419.9

    5 1419.95 13851401.3

    51410.65

    1427.77 1400.55 1374.571323.5

    30.0658

    3 4 + 9828-

    Aug-09 1392 1430 1390.051424.5

    51408.28

    1425.16 1404.79 1378.321362.6

    00.0335

    2 -2.375 - 9931-

    Aug-09 1432 1460 1425.1 1433.31432.65

    1426.3 1408.29 1383.11391.0

    30.0299

    2 24.4 + 100

    LOVELY PROFESSIONAL UNIVERSITY Page 38

  • 8/8/2019 Technical analysis of gsk PHARMA.

    39/63

    TECHNICAL ANALYSIS

    1-Sep-09 1447.8 1454 1436 1437.4

    1442.61426.81 1410.87 1388.22

    1374.55

    0.04951 9.95 +

    2-Sep-09 1441 1449.9 1431 1441.3 1441.15 1426.46 1414.2 1392.99 1358.83 0.06059 -1.45 - 1013-Sep-

    09 1460 1475 1421 1454.41457.2

    1426.76 1419.12 1397.471355.2

    80.0752

    1 16.1 + 1024-Sep-

    09 1455 1475 1436 1452.71453.85

    1428.86 1424.04 1401.531368.2

    50.0625

    6 -3.35 - 1037-Sep-

    09 1472 1485 14461461.6

    51466.83

    1432.95 1428.97 1405.491390.9

    50.0545

    5 13 + 1048-Sep-

    09 1460 1460 1450 14541457

    1437.69 1432.28 1409.041380.6

    5 0.0553 -9.825 - 1059-Sep-

    091461.1

    5 1462 1435.6 1439 1450.08 1442.03 1435.75 1412.391427.6

    30.0157

    3 -6.925 -10-

    Sep-09 1454.5 1495 14451459.4

    51456.98

    1446.66 1437.21 1415.921434.3

    30.0157

    9 6.9 + 10611-

    Sep-09 1464.3 1475 14251437.7

    51451.03

    1450.94 1438.05 1420.171421.2

    80.0209

    3 -5.95 - 10714-

    Sep-09 1440 1442.9 1427.15 1436.81438.4

    1451.51 1438.91 1422.71437.5

    00.0006

    3 -12.63 -15-

    Sep-09 1454.9 1465 1441.55 1459.61457.25

    1452.98 1439.89 1424.91444.6

    30.0087

    4 18.8 + 10816-

    Sep-09 1460 1473 1460

    1464.1

    5 1462.08 1455.07 1440.77 1427.82

    1454.2

    8

    0.0053

    6 4.83 +17-

    Sep-09 1466 1475 1460.5 1468.51467.25

    1456.07 1441.41 1431.431432.7

    80.0240

    6 5.17 +18-

    Sep-09 1485 1498 14751481.1

    51483.08

    1459 1443.93 1435.691426.0

    00.0400

    2 15.8 +24-

    Sep-09 1481 1496.7 1472.25 1480.11480.55

    1460.37 1446.66 1439.441409.6

    00.0503

    3 -2.525 - 10925-

    Sep-09 1490 1601.9 1482 1578.31534.15

    1468.08 1452.88 1444.211406.6

    50.0906

    4 53.6 + 110

    LOVELY PROFESSIONAL UNIVERSITY Page 39

  • 8/8/2019 Technical analysis of gsk PHARMA.

    40/63

    TECHNICAL ANALYSIS

    29-Sep-09 1599 1619.65 1555 1564.4

    1581.71481.25 1461.64 1450.91

    1410.65

    0.12126 47.6 +

    30-Sep-09 1572 1594 1543.1 1556.8 1564.4 1491.99 1469.32 1455.47 1408.28 0.11086 -17.3 - 1111-Oct-

    09 1562 1575 15451561.2

    51561.63

    1503.05 1476.99 1459.721432.6

    50.0900

    3 -2.775 -5-Oct-

    09 1560 1585 1550.21557.2

    51558.63

    1515.07 1483.29 1464.291442.6

    00.0804

    3 -3 -6-Oct-

    09 1566 1566 14901514.3

    51540.18

    1523.36 1488.17 1467.721441.1

    50.0687

    1 -18.45 -7-Oct-

    09 1455 1555 14551500.3

    51477.68

    1524.92 1490 1468.821457.2

    00.0140

    5 -62.5 -8-Oct-

    09 1504 1513 1425 1492.5 1498.25 1528.02 1492.05 1470.281453.8

    50.0305

    4 20.6 + 1129-Oct-

    09 1500 1537.9 14811519.2

    51509.63

    1530.68 1494.84 1472.851466.8

    30.0291

    8 11.4 +12-

    Oct-09 1534.9 1548.8 1519.3 1522.81528.85

    1535.51 1497.94 1476.271457.0

    00.0493

    1 19.2 +14-

    Oct-09 1525 1569 15251562.8

    51543.93

    1536.49 1502.28 1480.751450.0

    80.0647

    2 15.1 +15-

    Oct-09 1570 1636 1550.1 1554.71562.35

    1534.55 1507.9 1485.941456.9

    80.0723

    2 18.4 +16-

    Oct-09 1554 1616 1550

    1601.4

    5 1577.73 1535.88 1513.94 1491.51

    1451.0

    3

    0.0873

    2 15.4 +21-

    Oct-09 1609.9 1609.9 1598 1599.71604.8

    1540.2 1521.62 1498.061438.4

    00.1156

    8 27.1 +22-

    Oct-09 1600 1634.85 15901602.0

    51601.03

    1544.44 1529.76 1503.671457.2

    50.0986

    6 -3.775 - 11323-

    Oct-09 1607 1624.9 1607 1616.81611.9

    1551.61 1537.49 1509.321462.0

    80.1024

    7 10.9 + 11426-

    Oct-09 1555 1620 1535 1605.71580.35

    1561.88 1543.4 1513.961467.2

    50.0770

    8 -31.55 - 115

    LOVELY PROFESSIONAL UNIVERSITY Page 40

  • 8/8/2019 Technical analysis of gsk PHARMA.

    41/63

    TECHNICAL ANALYSIS

    27-Oct-09 1600 1606 1600 1600.4

    1600.21572.08 1550.05 1518.72

    1483.08

    0.07897 19.9 + 116

    28-Oct-09 1602 1615.6 1600 1612.1 1607.05 1581.82 1556.25 1523.83 1480.55 0.08544 6.85 +29-

    Oct-091600.0

    5 1612 16001600.6

    51600.35

    1588.97 1562.24 1528.281534.1

    50.0431

    5 -6.7 - 11730-

    Oct-09 1610 1615 1560 1578.31594.15

    1593.99 1565.24 1532.851581.7

    00.0078

    7 -6.2 -6-Nov-

    09 1585 1585 15511559.1

    51572.08

    1594.96 1564.76 1536.921564.4

    00.0049

    1 -22.08 -9-Nov-

    09 1567.9 1596 1558 1570.91569.4

    1594.13 1565.01 1540.671561.6

    30.0049

    8 -2.675 -10-

    Nov-09 1582 1593.5 1576.1 1584.1 1583.05 1591.96 1566.08 1545.071558.6

    30.0156

    7 13.6 + 11811-

    Nov-09 1585 1599 1581.051594.1

    51589.58

    1590.81 1567.63 1550.111540.1

    80.0320

    7 6.53 +12-

    Nov-09 1602 1602 1589 1597.61599.8

    1589.6 1570.61 1554.861477.6

    80.0826

    5 10.2 +13-

    Nov-09 1592.2 1655 1592.2 1637.31614.75

    1593.04 1577.46 1559.951498.2

    50.0777

    6 15 +16-

    Nov-09 1640 1671 16381665.1

    51652.58

    1598.28 1585.18 1566.131509.6

    30.0946

    9 37.8 +17-

    Nov-09 1670 1687 1655 1665.2 1667.6 1604.33 1593.08 1572.28

    1528.8

    5

    0.0907

    5 15 +18-

    Nov-09 1666.5 1699 1665 1682.91674.7

    1611.77 1600.37 1578.751543.9

    3 0.0847 7.1 +19-

    Nov-09 1673 1715.9 1673 1702.31687.65

    1621.12 1607.55 1583.861562.3

    5 0.0802 13 +20-

    Nov-09 1703 1715.95 16611676.8

    51689.93

    1632.9 1613.93 1587.471577.7

    30.0711

    2 2.27 +23-

    Nov-09 1710 1710 16651669.8

    51689.93

    1644.96 1619.54 1591.661604.8

    00.0530

    4 0 +

    LOVELY PROFESSIONAL UNIVERSITY Page 41

  • 8/8/2019 Technical analysis of gsk PHARMA.

    42/63

    TECHNICAL ANALYSIS

    24-Nov-09

    1668.05 1682.05 1652.35

    1658.55

    1663.31652.98 1622.47 1595.05

    1601.03 0.0389 -26.63 - 119

    25-Nov-09 1663.95 1663.95 1610.15 1619.1 1641.53 1658.18 1624.49 1597.81 1611.90 0.01838 -21.77 -26-

    Nov-09 1625 1645 1606.05 1634.71629.85

    1661.18 1625.39 1600.81580.3

    50.0313

    2 -11.68 -27-

    Nov-09 1640 1641 1601 1633.91636.95

    1663.4 1628.22 1606.111600.2

    00.0229

    7 7.1 + 12030-

    Nov-09 1633 1680 16201670.7

    51651.88

    1663.33 1630.8 1611.231607.0

    50.0278

    9 14.9 +1-Dec-

    09 1656.5 1701.9 1656.51686.9

    51671.73

    1663.74 1634.04 1616.631600.3

    5 0.0446 19.8 +2-Dec-

    09 1698 1698 1660.35 1663.5 1680.75 1664.35 1638.06 1621.691594.1

    50.0543

    2 9.03 +3-Dec-

    09 1670 1690 16501658.8

    51664.43

    1662.03 1641.57 1625.711572.0

    80.0587

    4 -16.33 - 1214-Dec-

    09 1642 1690 1642 16731657.5

    1658.78 1645.84 1628.881569.4

    00.0561

    4 -6.925 -7-Dec-

    09 1680 1690 1666 1676.91678.45

    1657.64 1651.3 1632.241583.0

    50.0602

    6 21 + 1228-Dec-

    09 1661.8 1682.8 1658 1667.11664.45

    1657.75 1655.37 1634.231589.5

    8 0.0471 -14 - 1239-Dec-

    09 1670 1678.95 1640

    1649.5

    5 1659.78 1659.58 1658.88 1636.19

    1599.8

    0

    0.0374

    9 -4.675 -10-

    Dec-09 1645 1650 1627 1633.91639.45

    1660.54 1660.86 1637.111614.7

    5 0.0153 -20.33 -11-

    Dec-09 1635 1652.9 1607 1615.91625.45

    1659.39 1661.39 1638.611652.5

    8 -0.0164 -14 -14-

    Dec-09 1610 1620 1597 1601.41605.7

    1654.77 1659.05 1638.791667.6

    0 -0.0371 -19.75 -15-

    Dec-09 1609 1627.9 15941603.6

    51606.33

    1648.23 1655.99 1638.771674.7

    0 -0.0408 0.63 + 124

    LOVELY PROFESSIONAL UNIVERSITY Page 42

  • 8/8/2019 Technical analysis of gsk PHARMA.

    43/63

    TECHNICAL ANALYSIS

    16-Dec-09 1600 1609.8 1590 1591.2

    1595.61639.71 1652.03 1638.61

    1687.65 -0.0545 -10.73 - 125

    17-Dec-09 1608.9 1608.9 1575 1578.6 1593.75 1632.65 1647.34 1638.6 1689.93 -0.0569 -1.85 -18-

    Dec-091591.9

    5 1645 1574 1606.11599.03

    1626.8 1642.79 1639.491689.9

    3 -0.0538 5.28 + 12621-

    Dec-09 1610 1635 15901609.6

    51609.83

    1619.94 1638.79 1640.841663.3

    0 -0.0321 10.8 +22-

    Dec-09 1611.1 1624.8 15781583.2

    51597.18

    1613.21 1635.48 1641.311641.5

    3 -0.027 -12.65 - 12723-

    Dec-091593.9

    5 1613 1593.95 1599.31596.63

    1606.89 1633.23 1641.551629.8

    5 -0.0204 -0.55 -24-

    Dec-09 1605 1655 1591.25 1646.3 1625.65 1605.51 1633.02 1642.411636.9

    5 -0.0069 29 + 12829-

    Dec-09 1654.5 1655 15901594.0

    51624.28

    1605.4 1632.39 1642.731651.8

    8 -0.0167 -1.375 - 12930-

    Dec-09 1595 1615 15851610.7

    51602.88

    1605.11 1629.94 1641.071671.7

    3 -0.0412 -21.4 -31-

    Dec-09 1615 1617 16001610.0

    51612.53

    1605.73 1626.98 1639.231680.7

    5 -0.0406 9.65 + 1304-Jan-

    101602.0

    5 1625 1602.05 1621.81611.93

    1607.37 1623.54 1637.141664.4

    3 -0.0315 -0.6 -5-Jan-

    10

    1612.2

    5 1633 1612.15

    1617.1

    5 1614.7 1609.46 1621.05 1634.71

    1657.5

    0 -0.0258 2.78 + 1316-Jan-

    101650.0

    5 1650.05 16121639.3

    51644.7

    1614.03 1620.41 1633.21678.4

    5 -0.0201 30 +7-Jan-

    10 1649 1654.9 16391647.9

    51648.48

    1617.89 1618.91 1631.821664.4

    5 -0.0096 3.78 +8-Jan-

    10 1631 1650 1631 1639.91635.45

    1621.72 1617.46 1630.891659.7

    8 -0.0147 -13.02 - 13211-Jan-

    10 1741 1741 1615.51626.6

    51683.83

    1630.44 1618.67 1632.31639.4

    50.0270

    7 48.4 + 133

    LOVELY PROFESSIONAL UNIVERSITY Page 43

  • 8/8/2019 Technical analysis of gsk PHARMA.

    44/63

    TECHNICAL ANALYSIS

    12-Jan-10

    1638.95 1638.95 1582.25

    1586.45

    1612.71629.15 1617.33 1631.73

    1625.45 -0.0078 -71.13 - 134

    13-Jan-10 1590 1610 1566 1571.2 1580.6 1624.78 1615.09 1629.85 1605.70 -0.0156 -32.1 -14-Jan-

    101560.1

    5 1599.8 1560.151573.8

    51567

    1621.19 1613.15 1627.021606.3

    3 -0.0245 -13.6 -15-Jan-

    101584.9

    5 1585 1570 1572.31578.63

    1617.8 1611.77 1623.921595.6

    0 -0.0106 11.6 + 13518-Jan-

    10 1572 1575 1561.05 1562.31567.15

    1613.32 1610.34 1620.131593.7

    5 -0.0167 -11.47 - 13619-Jan-

    10 1582.5 1582.5 15551557.6

    51570.08

    1608.86 1609.16 1616.991599.0

    3 -0.0181 2.92 + 13720-Jan-

    10 1565 1581.3 15511558.6

    5 1561.83 1600.57 1607.3 1613.81609.8

    3 -0.0298 -8.25 - 13821-Jan-

    101561.8

    5 1561.85 1500 1539.21550.53

    1590.78 1604.34 1609.541597.1

    8 -0.0292 -11.3 -22-Jan-

    10 1510 1533 1490.11512.6

    51511.33

    1578.37 1600.04 1604.431596.6

    3 -0.0534 -39.2 -25-Jan-

    101517.8

    5 1535 1505 15291523.43

    1562.33 1596.38 1599.891625.6

    5 -0.0629 12.1 + 13927-Jan-

    10 1520 1544 1502.15 1525.21522.6

    1553.32 1591.23 1595.991624.2

    8 -0.0626 -0.825 - 14028-Jan-

    10 1544 1545 1515

    1533.0

    5 1538.53 1549.11 1586.94 1593.09

    1602.8

    8 -0.0401 15.9 + 14129-Jan-

    10 1538 1538 1509.051520.1

    51529.08

    1545.32 1583.25 1590.541612.5

    3 -0.0518 -9.45 - 1421-Feb-

    10 1500 1548 15001543.5

    51521.78

    1539.63 1578.72 1587.721611.9

    3 -0.0559 -7.3 -2-Feb-

    101554.9

    5 1560 1536 1537.41546.18

    1537.53 1575.43 1586.071614.7

    0 -0.0424 24.4 + 1433-Feb-

    10 1540 1575 1535 1560.81550.4

    1535.57 1572.21 1584.631644.7

    0 -0.0573 4.22 +

    LOVELY PROFESSIONAL UNIVERSITY Page 44

  • 8/8/2019 Technical analysis of gsk PHARMA.

    45/63

    TECHNICAL ANALYSIS

    4-Feb-10 1571.8 1571.8 1555.2 1560

    1565.91535.97 1568.27 1583.52

    1648.48 -0.0501 15.5 +

    5-Feb-10 1523 1569.9 1510.55 1553.95 1538.48 1534.77 1562.77 1581.15 1635.45 -0.0593 -27.43 - 1448-Feb-

    10 1569.8 1570 1509 1525.51547.65

    1538.4 1558.38 1579.51683.8

    3 -0.0809 9.18 + 1459-Feb-

    10 1530 1535 1511.05 1530.41530.2

    1539.08 1550.7 1577.281612.7

    0 -0.0512 -17.45 - 14610-

    Feb-101541.9

    5 1565 1535.1 1556.31549.13

    1541.73 1547.52 1574.731580.6

    0 -0.0199 18.9 + 14715-

    Feb-101619.8

    5 1619.85 15701576.8

    51598.35

    1547.71 1548.41 1573.871567.0

    00.0200

    1 49.2 +16-

    Feb-10 1590 1599.95 1551.15 1565.3 1577.65 1552.57 1548.94 1573.031578.6

    3 -0.0006 -20.7 - 14817-

    Feb-101574.4

    5 1585 1571.151580.3

    51577.4

    1558.13 1548.88 1571.851567.1

    50.0065

    4 -0.25 -18-

    Feb-10 1582 1590 1574 1581.71581.85

    1561.7 1549.62 1570.851570.0

    8 0.0075 4.45 + 14919-

    Feb-10 1578 1655 15781649.6

    51613.83

    1568.04 1551.8 1570.821561.8

    30.0332

    9 32 +22-

    Feb-10 1652 1684.95 16451681.7

    51666.88

    1578.14 1557.06 1571.561550.5

    30.0750

    4 53.1 +23-

    Feb-10 1686 1731 1662.15 1705.4 1695.7 1593.86 1564.32 1573.14

    1511.3

    3 0.122 28.8 +24-

    Feb-10 1690 1719.9 1680.2 1710.71700.35

    1609.13 1573.77 1575.31523.4

    30.1161

    4 4.65 +25-

    Feb-10 1700 1730 1700 1722.51711.25

    1627.24 1583.16 1576.211522.6

    0 0.1239 10.9 +26-

    Feb-10 1722 1722 1707 1715.51718.75

    1644.2 1592.97 1579.751538.5

    30.1171

    4 7.5 +2-Mar-

    10 1700 1719.9 17001702.0

    51701.03

    1654.47 1601.09 1583.761529.0

    80.1124

    5 -17.72 - 150

    LOVELY PROFESSIONAL UNIVERSITY Page 45

  • 8/8/2019 Technical analysis of gsk PHARMA.

    46/63

    TECHNICAL ANALYSIS

    3-Mar-10 1718 1719 1702 1711

    1714.51668.15 1610.36 1588.68

    1521.78

    0.12664 13.5 + 151

    4-Mar-10 1718.8 1785 1715 1740.45 1729.63 1683.38 1620.75 1593.71 1546.18 0.11865 15.1 +5-Mar-

    10 1740.5 1768 1730 1737.81739.15

    1699.11 1630.4 1599.451550.4

    00.1217

    4 9.53 +8-Mar-

    10 1750 1779.95 1750 1770.11760.05

    1713.73 1640.89 1605.781565.9

    00.1239

    9 20.9 +9-Mar-

    10 1770.5 1777.35 1737.951750.5

    51760.53

    1723.09 1650.62 1612.41538.4

    80.1443

    3 0.48 +10-

    Mar-10 1742 1770 1730.21766.1

    51754.08

    1728.93 1661.4 1619.191547.6

    50.1333

    8 -6.45 - 15211-

    Mar-101752.2

    5 1770 1731.051744.9

    5 1748.6 1733.76 1671.44 1627.11530.2

    00.1427

    3 -5.475 -12-

    Mar-10 1756.5 1769.85 1715.251731.8

    51744.18

    1737.05 1682.14 1634.451549.1

    30.1259

    1 -4.425 -15-

    Mar-10 1743 1743 1696 1698.11720.55

    1737.23 1690.71 1641.051598.3

    50.0764

    5 -23.63 -16-

    Mar-10 1685 1713 16841700.8

    51692.93

    1736.42 1695.44 1646.21577.6

    50.0730

    7 -27.63 -17-

    Mar-10 1650 1718.5 1650 1692.11671.05

    1732.07 1700.11 1650.931577.4

    00.0593

    7 -21.88 -18-

    Mar-10

    1699.9

    5 1710 1683

    1703.0

    5 1701.5 1729.26 1706.32 1656.92

    1581.8

    5

    0.0756

    4 30.5 + 15319-

    Mar-10 1705 1737.5 17051725.0

    51715.03

    1726.85 1712.98 1662.551613.8

    30.0627

    1 13.5 +22-

    Mar-10 1720 1754.4 1720 1736.71728.35

    1723.68 1718.7 1668.481666.8

    80.0368

    8 13.3 +23-

    Mar-10 1731.1 1750 1731.11745.9

    51738.53

    1721.48 1722.29 1674.241695.7

    00.0252

    6 10.2 +25-

    Mar-10 1748 1755.5 1737.051748.3

    51748.18

    1720.89 1724.91 1681.231700.3

    50.0281

    3 9.65 +

    LOVELY PROFESSIONAL UNIVERSITY Page 46

  • 8/8/2019 Technical analysis of gsk PHARMA.

    47/63

    TECHNICAL ANALYSIS

    26-Mar-10 1670 1755 1670 1749

    1709.51716.98 1725.37 1686.62

    1711.25 -0.001 -38.68 - 154

    29-Mar-10 1745 1760 1745 1756.2 1750.6 1717.62 1727.33 1693.97 1718.75 0.01853 41.1 +30-

    Mar-10 1760 1775 1750.051774.9

    51767.48

    1722.31 1729.77 1701.251701.0

    30.0390

    6 16.9 +31-

    Mar-10 1716 1780.5 17161777.8

    51746.93

    1727.71 1732.07 1706.21714.5

    00.0189

    1 -20.55 - 1551-Apr-

    10 1782.1 1784.9 1751.31763.6

    51772.88

    1737.9 1734.98 1712.711729.6

    30.0250

    1 26 + 1565-Apr-

    101784.9

    5 1797 1751.11781.5

    51783.25

    1746.07 1737.67 1719.571739.1

    50.0253

    6 10.4 +6-Apr-

    10 1790 1790 1758

    1761.6

    5 1775.83 1752.15 1739.5 1726.03

    1760.0

    5

    0.0089

    6 -7.425 - 1577-Apr-

    10 1763 1782 1750 17581760.5

    1755.37 1739.52 1730.921760.5

    3 -1E-05 -15.33 -8-Apr-

    10 1785 1785 1752.3 1765.61775.3

    1759.04 1740.26 1734.541754.0

    8 0.0121 14.8 + 1589-Apr-

    10 1762.2 1782.95 1762.21780.2

    51771.23

    1761.35 1741.12 1737.061748.6

    00.0129

    4 -4.075 - 15912-

    Apr-10 1775 1791 1770 1788.11781.55

    1768.55 1742.77 1739.761744.1

    80.0214

    3 10.3 + 16013-

    Apr-10 1776.2 1806 1776.2 1800.8 1788.5 1772.34 1744.98 1742.34

    1720.5

    5

    0.0394

    9 6.95 +15-

    Apr-10 1807 1824.75 17911810.1

    51808.58

    1776.45 1749.38 1745.331692.9

    30.0683

    1 20.1 +16-

    Apr-10 1800 1850 1800 1823.11811.55

    1782.92 1755.31 1749.021671.0

    50.0840

    8 2.97 +19-

    Apr-10 1812.5 1861 1812.05 1847.71830.1

    1788.64 1763.27 1752.871701.5

    00.0755

    8 18.6 +20-

    Apr-10 1848 1865 1847.31856.1

    51852.08

    1795.52 1770.8 1756.951715.0

    30.0799

    1 22 +

    LOVELY PROFESSIONAL UNIVERSITY Page 47

  • 8/8/2019 Technical analysis of gsk PHARMA.

    48/63

    TECHNICAL ANALYSIS

    21-Apr-10

    1864.95 1933 1851.4

    1920.05

    1892.51807.19 1779.67 1762.06

    1728.35

    0.09497 40.4 +

    22-Apr-10 1925 1925 1890 1903.4 1914.2 1822.56 1788.96 1767.2 1738.53 0.10105 21.7 +23-

    Apr-10 1940 1940 18871897.2

    51918.63

    1836.89 1797.97 1772.471748.1

    8 0.0975 4.42 +26-

    Apr-101896.8

    5 1902.9 1873 1881.81889.33

    1848.7 1805.02 1776.981709.5

    00.1051

    9 -29.3 - 16127-

    Apr-101932.6

    5 1932.65 1880.05 1883.91908.28

    1861.37 1814.96 1782.31750.6

    00.0900

    7 19 + 16228-

    Apr-10 1890 1914.9 18751898.6

    51894.33

    1871.96 1822.15 1787.311767.4

    80.0717

    7 -13.95 - 16329-

    Apr-10 1910 1918.95 1876.05 1881.1 1895.55 1880.65 1828.55 1793.14

    1746.9

    3

    0.0850

    8 1.22 + 16430-

    Apr-10 1892.5 1915 18621905.0

    51898.78

    1889.38 1836.15 18001772.8

    80.0710

    1 3.23 +3-May-

    10 1890.1 1925 18181898.3

    51894.23

    1895.79 1842.21 1807.441783.2

    50.0622

    3 -4.55 - 1654-May-

    10 1886.5 1907 1870 1894.51890.5

    1899.63 1847.58 1813.741775.8

    30.0645

    8 -3.725 -5-May-

    10 1971 1971 1897.45 1942.61956.8

    1906.06 1856.62 1821.81760.5

    0 0.1115 66.3 + 1666-May-

    10

    1948.8

    5 1991 1944.05

    1982.1

    51965.5

    1911.19 1866.87 1829.7

    1775.3

    0

    0.1071

    4 8.7 +7-May-

    10 1961 1974.95 1935.3 1944.31952.65

    1914.59 1875.74 1836.841771.2

    30.1024

    3 -12.85 - 16710-

    May-10 1959 2013.7 1959

    1989.25

    1974.131923.07 1885.89 1844.37

    1781.55

    0.10809 21.5 + 168

    11-May-

    10 1955 2013 19551985.2

    51970.13

    1929.26 1895.32 1853.06

    1788.50

    0.10155 -4 - 169

    LOVELY PROFESSIONAL UNIVERSITY Page 48

  • 8/8/2019 Technical analysis of gsk PHARMA.

    49/63

    TECHNICAL ANALYSIS

    12-May-

    10 2000.1 2064 19902054.6

    52027.38

    1942.56 1907.26 1862.29

    1808.58

    0.12098 57.3 + 170

    13-May-

    10 2070 2149 2056.05 2129.82099.9

    1963 1921.83 1873.37

    1811.55

    0.15917 72.5 +

    14-May-

    10 2130 2147 2101 2137.42133.7

    1986.49 1937.93 1886.26

    1830.10

    0.16589 33.8 +

    17-May-

    10 2137.4 2174.95 21102159.1

    52148.28

    2011.9 1953.84 1898.77

    1852.08

    0.15993 14.6 +

    18-

    May-10

    2157.05 2271 2157.05 2173

    2165.032039.35 1969.49 1911.5

    1892.500.144 16.8 +

    19-May-

    10 2175 2175 2054 2070.22122.6

    2055.93 1980.99 1923.06

    1914.20

    0.10887 -42.43 - 171

    20-May-

    102099.9

    5 2105 2031 2084.32092.13

    2068.59 1989.89 1934.11

    1918.63

    0.09043 -30.47 -

    21-May-

    10 2064 2095 2016.35 2044.2

    2054.1

    2078.74 1996.66 1943.41

    1889.33

    0.0872

    1 -38.03 -24-

    May-10

    2134.95 2134.95 2020.1 2028.6

    2081.782089.5 2006.29 1953.76

    1908.28

    0.09092 27.7 + 172

    25-May-

    10 2060 2060 1995.152009.5

    52034.78

    2095.97 2012.61 1962.2

    1894.33

    0.07414 -47 - 173

    26-May-

    10 2078 2078 1992.62002.8

    52040.43

    2097.27 2019.92 1970.6

    1895.55

    0.07643 5.65 + 174

    LOVELY PROFESSIONAL UNIVERSITY Page 49

  • 8/8/2019 Technical analysis of gsk PHARMA.

    50/63

    TECHNICAL ANALYSIS

    27-May-

    10 2020 2020 19551982.2

    52001.13

    2087.39 2025.2 1977.01

    1898.78

    0.0539 -39.3 - 17528-

    May-10 1975 2035 1971.5 1996.3

    1985.652072.59 2029.54 1982.82

    1894.23

    0.04827 -15.47 -

    31-May-

    10 2025 2115.5 19922105.9

    52065.48

    2064.31 2038.1 1990.66

    1890.50

    0.09255 79.8 + 176

    1-Jun-10 2056.6 2130 2041.15

    2088.85

    2072.732055.08 2047.21 1998.02

    1956.80

    0.05924 7.25 +

    2-Jun-10 2090 2124.95 2075.8

    2105.85

    2097.932052.61 2054.27 2004.87

    1965.50

    0.06737 25.2 +

    3-Jun-10 2111 2111.95 2059 2078.9

    2094.952052.89 2060.74 2010.89

    1952.65

    0.07288 -2.975 - 177

    4-Jun-10 2110 2110 2035.1 2038.7

    2074.352054.92 2066.83 2016.08

    1974.13

    0.05077 -20.6 -

    7-Jun-10 2038.7 2057 2008

    2028.55

    2033.632050.1 2069.8 2020.89

    1970.13

    0.03223 -40.72 -

    8-Jun-10

    2020.05 2085 2020.05

    2025.25

    2022.652048.89 2072.43 2024.7

    2027.38 -0.0023 -10.97 -

    9-Jun-10 2120 2128.8 2041.05

    2101.55

    2110.782055.93 2076.6 2031.92

    2099.90

    0.00518 88.1 + 178

    10-Jun-10 2120 2134.9 2091.15

    2101.85

    2110.932066.91 2077.15 2039.1

    2133.70 -0.0107 0.15 +

    11-Jun-10

    2138.95 2138.95 2041 2075.6

    2107.282079.07 2075.83 2046.05

    2148.28 -0.0191 -3.65 - 179

    14-Jun-10 2124.9 2124.9 2071.15 2076.8

    2100.852082.61 2073.46 2052.94

    2165.03 -0.0296 -6.425 -

    15-Jun-10

    2098.85 2109.95 2060

    2078.45

    2088.652084.2 2069.64 2059.54

    2122.60 -0.016 -12.2 -

    16-Jun-10 2050 2100 2050 2079.5

    2064.752080.88 2066.75 2063.14

    2092.13 -0.0131 -23.9 -

    LOVELY PROFESSIONAL UNIVERSITY Page 50

  • 8/8/2019 Technical analysis of gsk PHARMA.

    51/63

    TECHNICAL ANALYSIS

    17-Jun-10 2100 2116.9 2080 2092.9

    2096.452081.03 2066.96 2067.5

    2054.10

    0.02062 31.7 + 180

    18-Jun-10

    2109.95 2120 2072.25 2079 2094.48 2083.04 2068.98 2072.23

    2081.78 0.0061 -1.975 - 181

    21-Jun-10 2114.8 2136 2095.5

    2127.45

    2121.132091.79 2070.95 2077.13

    2034.78

    0.04244 26.7 + 182

    22-Jun-10 2140 2171.45 2091 2100.7

    2120.352101.56 2075.23 2082.14

    2040.43

    0.03917 -0.775 - 183

    23-Jun-10

    2119.95 2135.7 2094

    2115.85

    2117.92102.28 2079.1 2085.16

    2001.13

    0.05835 -2.45 -

    24-Jun-10 2125.5 2158.8 2116.05 2140.7

    2133.12104.49 2085.7 2086.26

    1985.65

    0.07426 15.2 + 184

    25-Jun-

    10 2150 2184.7 2150 2169.1 2159.55 2109.72 2094.39 2087.13

    2065.4

    8

    0.0455

    5 26.5 +28-Jun-

    10 2181.5 2200 2180 2184.92183.2

    2117.96 2100.28 2088.292072.7

    3 0.0533 23.6 +29-Jun-

    10 2200 2225 2195 2211.22205.6

    2129.65 2106.92 2089.642097.9

    30.0513

    2 22.4 +30-Jun-

    10 2180 2230 2171.552190.7

    52185.38

    2141.71 2111.3 2091.732094.9

    50.0431

    6 -20.22 - 1851-Jul-

    102205.7

    5 2213.5 2176 2187.62196.68

    2151.74 2116.38 2095.222074.3

    50.0589

    7 11.3 + 1862-Jul-

    10

    2100.2

    5 2215 2092

    2162.1

    52131.2

    2155.41 2119.23 2097.79

    2033.6

    3

    0.0479

    8 -65.48 - 1875-Jul-

    10 2201 2201 2150 2164.12182.55

    2161.55 2126.67 2101.152022.6

    50.0790

    5 51.4 + 1886-Jul-

    102195.9

    5 2195.95 2125 2136.82166.38

    2166.15 2133.86 2105.542110.7

    80.0263

    4 -16.18 - 1897-Jul-

    10 2175 2175 2125 2129.22152.1

    2169.57 2135.92 2109.262110.9

    30.0195

    1 -14.28 -8-Jul-

    10 2180 2180 21302135.3

    52157.68

    2172.03 2138.26 2114.482107.2

    80.0239

    2 5.58 + 190

    LOVELY PROFESSIONAL UNIVERSITY Page 51

  • 8/8/2019 Technical analysis of gsk PHARMA.

    52/63

    TECHNICAL ANALYSIS

    9-Jul-10

    2152.15 2152.15 2104

    2112.35

    2132.252169.3 2139.51 2119.36

    2100.85

    0.01495 -25.43 - 191

    12-Jul-10 2115 2131.85 2075 2084.9 2099.95 2160.98 2139.47 2120.51

    2088.65

    0.00541 -32.3 -

    13-Jul-10 2093.5 2102.55 2039

    2046.45

    2069.982147.41 2138.53 2120.42

    2064.75

    0.00253 -29.97 -

    14-Jul-10 2058.3 2115.9 2055.3

    2081.25

    2069.782135.85 2138.78 2119.48

    2096.45 -0.0127 -0.2 -

    15-Jul-10 2090 2108 2062.3

    2070.45

    2080.232124.21 2137.97 2118.99

    2094.48 -0.0068 10.4 + 192

    16-Jul-10 2070 2070 2030.1

    2062.75

    2066.382117.73 2136.57 2118.73

    2121.13 -0.0258 -13.85 - 193

    19-Jul-

    10 2041.5 2064 2041.5 2049.5 2045.5 2104.02 2132.79 2119.12

    2120.3

    5 -0.0353 -20.88 -20-Jul-

    10 2062 2062 2019.052026.2

    52044.13

    2091.8 2128.97 2119.842117.9

    0 -0.0348 -1.375 -21-Jul-

    10 2027 2039.95 20252027.8

    52027.43

    2079.33 2124.45 2117.062133.1

    0 -0.0495 -16.7 -22-Jul-

    10 2044.5 2044.5 20052030.1

    52037.33

    2067.29 2119.66 2114.612159.5

    5 -0.0566 9.9 + 19423-Jul-

    10 2036 2091.4 2033.62074.5

    52055.28

    2059.6 2114.45 2112.872183.2

    0 -0.0586 18 +26-Jul-

    10 2099 2110 2054.05 2062.72080.85

    2057.69 2109.33 2112.21

    2205.6

    0 -0.0566 25.6 +27-Jul-

    10 2071 2084.95 2051.052056.8

    52063.93

    2057.08 2102.25 2111.382185.3

    8 -0.0556 -16.92 - 19528-Jul-

    10 2066.5 2104.55 2060.5 2067.42066.95

    2056.8 2096.33 2111.452196.6

    8 -0.0591 3.02 + 19629-Jul-

    10 2070 2070 2020.2 2024.92047.45

    2053.52 2088.86 2109.822131.2

    0 -0.0393 -19.5 - 19729-Jul-

    10 2070 2070 2020.2 2024.92047.45

    2051.63 2084.68 2108.252182.5

    5 -0.0619 0

    LOVELY PROFESSIONAL UNIVERSITY Page 52

  • 8/8/2019 Technical analysis of gsk PHARMA.

    53/63

    TECHNICAL ANALYSIS

    30-Jul-10 2038.2 2038.2 2000 2015.8

    20272049.78 2076.9 2105.12

    2166.38 -0.0643 -20.45 - 198

    3-Aug-10 2030.4 2030.4 2001.25 2004.9 2017.65 2047.13 2069.46 2101.69

    2152.10 -0.0625 -9.35 -

    4-Aug-10 2010 2035 1984 2000

    20052044.89 2062.11 2097.93

    2157.68 -0.0708 -12.65 -

    5-Aug-10 2020 2030 1995 2011.9

    2015.952042.75 2055.02 2094.02

    2132.25 -0.0545 11 + 199

    6-Aug-10 2019.9 2028.7 2010 2017.1

    2018.52039.07 2049.33 2089.32

    2099.95 -0.0388 2.55 +

    9-Aug-10 2020 2058 1990

    1997.45

    2008.732031.86 2044.77 2083.51

    2069.98 -0.0296 -9.775 - 200

    10-

    Aug-10 2010 2035 1980

    1990.7

    5 2000.38 2025.51 2041.29 2076.67

    2069.7

    8 -0.0335 -8.35 -11-

    Aug-10 2032 2032 19491958.3

    51995.18

    2018.33 2037.56 2070.332080.2

    3 -0.0409 -5.2 -12-

    Aug-101957.0

    5 1965 19421953.5

    51955.3

    2009.11 2031.32 2062.282066.3

    8 -0.0538 -39.88 -13-

    Aug-10 1951 1985 19421960.9

    51955.98

    1999.97 2025.8 2056.442045.5

    0 -0.0438 0.67 + 20116-

    Aug-10 1971.2 1988 1941 19461958.6

    1993.13 2021.45 2048.972044.1

    3 -0.0418 2.63 +17-

    Aug-10 1950 1968.9 1942.05

    1961.7

    51955.88

    1986.95 2017.04 2041.96

    2027.4

    3 -0.0353 -2.725 - 20218-

    Aug-10 1953 1969.5 1940 1944.41948.7

    1981.32 2013.1 2035.182037.3

    3 -0.0435 -7.175 -19-

    Aug-10 1943 1988.8 19351980.7

    51961.88

    1975.91 2009.33 2028.652055.2

    8 -0.0454 13.2 + 20320-

    Aug-10 1990 2040 1981.05 2015.92002.95

    1974.36 2006.71 2024.342080.8

    5 -0.0374 41.1 +23-

    Aug-10 2039 2040.95 1966 1975.72007.35

    1974.22 2003.04 2021.252063.9

    3 -0.0274 4.4 +

    LOVELY PROFESSIONAL UNIVERSITY Page 53

  • 8/8/2019 Technical analysis of gsk PHARMA.

    54/63

    TECHNICAL ANALYSIS

    24-Aug-10 1975 2015 1940

    1946.45

    1960.731970.25 1997.88 2017.61

    2066.95 -0.0514 -46.63 - 204

    25-Aug-10

    1944.95 1945 1880

    1883.15 1914.05 1962.14 1990.23 2012.42

    2047.45 -0.0652 -46.67 -

    26-Aug-10 1890 1895 1852 1871.9

    1880.951954.71 1981.91 2005.78

    2047.45 -0.0813 -33.1 -

    27-Aug-10 1880 1912 1860 1869.4

    1874.71946.58 1973.27 1999.39

    2027.00 -0.0751 -6.25 -

    30-Aug-10 1890 1907.9 1885.15 1890.6

    1890.31939.75 1966.44 1994.22

    2017.65 -0.0631 15.6 + 205

    31-Aug-10 1897.9 1899 1850 1861.2

    1879.551932.12 1959.53 1988.73

    2005.00 -0.0626 -10.75 - 206

    1-Sep-

    10

    1899.6

    5 1899.65 1876.05

    1879.4

    5 1889.55 1926.2 1953.76 1984.14

    2015.9

    5 -0.0627 10 + 2072-Sep-

    10 1885 1935 1880 1909.71897.35

    1919.75 1947.83 1979.472018.5

    0 -0.06 7.8 +3-Sep-

    10 1925 1930 19121917.8

    51921.43

    1911.6 1942.98 1975.012008.7

    3 -0.0435 24.1 +6-Sep-

    10 1939 1939 1916.51917.6

    51928.33

    1903.69 1938.96 1969.922000.3

    8 -0.036 6.9 +7-Sep-

    10 1916.5 1928.95 1916 1916.71916.6

    1899.28 1934.77 1965.011995.1

    8 -0.0394 -11.73 - 2088-Sep-

    10 1900 1922.95 1900

    1917.4

    51908.73

    1898.75 1930.44 1959.74

    1955.3

    0 -0.0238 -7.875 -9-Sep-

    10 1915 1924.9 1906.61916.6

    51915.83

    1902.24 1928.47 1955.351955.9

    8 -0.0205 7.1 + 20924-

    Sep-10 2050 2134 20502110.9

    52080.48

    1922.81 1934.7 1956.451958.6

    00.0622

    3 165 +27-

    Sep-10 2140 2157.9 2091.52144.2

    52142.13

    1948 1943.87 1960.291955.8

    80.0952

    3 61.7 +28-

    Sep-10 2150 2171 2130.252153.3

    52151.68

    1975.21 1953.66 1964.761948.7

    00.1041

    6 9.55 +

    LOVELY PROFESSIONAL UNIVERSITY Page 54

  • 8/8/2019 Technical analysis of gsk PHARMA.

    55/63

    TECHNICAL ANALYSIS

    29-Sep-10 2163 2251 2163 2243.9

    2203.452006.6 1966.4 1971.37

    1961.88

    0.12313 51.8 +

    30-Sep-10 2240 2284.9 2199.5 2209.7 2224.85 2039.35 1979.55 1978.34

    2002.95

    0.11079 21.4 +

    Total 4328 -3285

    G4327.7

    3

    L3284.8

    0

    No. of Gain 251

    No.of Lose 219

    Daily Average gain 17.24

    Daily Average lose 15.00

    Relative strength 1.15

    Relative strength ofindex 53.48

    LOVELY PROFESSIONAL UNIVERSITY Page 55

  • 8/8/2019 Technical analysis of gsk PHARMA.

    56/63

    TECHNICAL ANALYSIS

    MOVING AVERAGE

    An indicator frequently used in technical analysis showing the average value of a security's price over a set period. Moving averages are generally

    used to measure momentum and define areas of possible support and resistance.

    In this, I have calculate three moving average on the bases of 10 days , 20days and 30 days.

    Moving average charts is a tool used by technical analysts to track the price movements of a security. It plots average daily settlement prices over

    a defined period of time like 10 days, 20 days, and 30 days.

    INTERPETATION

    LOVELY PROFESSIONAL UNIVERSITY Page 56

  • 8/8/2019 Technical analysis of gsk PHARMA.

    57/63

    TECHNICAL ANALYSIS

    As per tree different period moving average charts show the trend of GSK in BSE.10 days and less than 10 days moving average is helpful

    for short term investment .For long term investors 30 days moving average and more than 30 days moving average is helpful for investment in

    stock market.

    Here GSK market performance was good and its moving average trend is in increasing form. Moving averages can be used to quickly

    identify whether a security is moving in an uptrend or a downtrend depending on the direction of the moving average. As charts when a moving

    average is heading upward and the price is above it, the security is in an uptrend. Conversely, a downward sloping moving average with the price

    below can be used to signal a downtrend.

    RELATIONSHIP BETWEEN SHARE PRICE AND MOVING AVERAGE

    INTERPETATION

    As shown in the above chart, the market price is below the moving average line also both the market price and moving average is moving along

    the line, also it has reached the resistance level, hence it is advisable to long term investors to sell the share and book the profit at the same time itadvisable to the short term investors to buy the share and hold it for mere future and sell it when it reaches the support level. Thus it is good sign

    to sell to long term investors

    OSCELLATOR

    Oscellator is a technical analysis tool that is banded between two extreme values and built with the results from a trend indicator for discovering

    short-term overbought or oversold conditions. As the value of the oscillator approaches the upper extreme value the asset is deemed to be

    overbought, and as it approaches the lower extreme it is deemed to be oversold.

    LOVELY PROFESSIONAL UNIVERSITY Page 57

  • 8/8/2019 Technical analysis of gsk PHARMA.

    58/63

    TECHNICAL ANALYSIS

    INTERPETATION

    According to GSK oscillator chart, company oscillator value 1.9583 on 25 Nov 2008. This is the highest value of last two years, this is the

    position of over brought so, this is the moment where investors should sell their investmentment, and move towards another investvestment where

    there is a great prospect of profitability. When we move further and a glance of data from1dec 08 to 30sep10 the maximum achievable value is

    on 25 nov 2008. But when we move towards minimum level the maximum oversold position is on 3 nov 2008 i.e. -0.1241 that is the position

    where an investor should invest in the particular stock or if an exist investor then shoud hold the stock till it reaches it maximum level.

    If we talk about 30 sep 2010 then we get the value near than over brought so, it is a the time where investor should sold the stock, and for new

    investor that not to purchase the particular stock in the mean time. Because, when the market correction will done the value of stock definitely

    decreases.

    HEAD AND SHOULDERS

    A head and shoulders pattern is also a trend reversal formation. It is formed by a peak (shoulder), followed by a higher peak (head), and then

    another lower peak (shoulder). A "neckline" is drawn by connecting the lowest points of the two troughs. The slope of this line can either be up or

    down. Typically, when the slope is down, it produces a more reliable signal.

    LOVELY PROFESSIONAL UNIVERSITY Page 58

    OVER BOUGHT

    OVER SOLD

  • 8/8/2019 Technical analysis of gsk PHARMA.

    59/63

    TECHNICAL ANALYSIS

    Interpretation:-

    When we show the head and shoulder chart we find an uneven trend of stock movement, because there is number of head and shoulders drawn

    over a period of time, and if we talk about movement of stock of last two years there is a increasing trend follow by the stock, as we learn earlier

    that a upward stock movement is not so reliable due to this the current scenario is not the positive for the investment. Because, from 1 st oct 08 to

    30th sep 10 the head and shoulder movement is purely upward so, there is not a good time to investment as this point at 30 th sep of near about 2200

    so, it is the situation where investor should sale its investment and not the purchase of the same stock.

    CANDLE STICK CHAR